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LIFESTYLE CONTRIBUTORS TO CARDIOVASCULAR DISEASE RISK 
 
Aortic stiffness is an independent risk factor that has prognostic value regarding 
future cardiovascular disease (CVD) events such as myocardial infarction, 
strokes, and heart failure.  Although death rates due to coronary heart disease 
have declined in recent years, the leading global killer remains CVD and 
prevalence is still high.  Understanding lifestyle contributors associated with 
aortic stiffness would provide the public with insight into targeting key health-
related behaviors.   
 
The purpose of this observational study was to examine the association of 
physical activity, physical function, and dietary quality as independent factors 
contributing to aortic stiffness in apparently healthy middle aged men.  Fifty-two 
men between the ages of 30 and 59 years were recruited to participate in this 
study, which required two visits to the Exercise Physiology Laboratory.  Aortic 
stiffness was measured by aortic pulse wave velocity (aPWV) and was not 
associated with total daily step counts (r=-0.06; P=0.70).  However, aortic 
stiffness was inversely associated with physical function, determined with the 
sitting-rising test score (r=-0.44; P<0.01) and inversely associated with relative 
muscular strength, determined with peak handgrip strength in both hands 
normalized to body mass (r=-0.41; P<0.01).  Additionally, aortic stiffness was 
inversely associated with dietary quality, determined with the Healthy Eating 
Index score (r=0.51; P<0.01).   
 
In conclusion, key health-related behaviors in this study that explained a large 
percentage of the variation in aortic stiffness were physical function and dietary 
quality (Adj r²=0.47; SEE=0.634).  Hence, optimizing overall musculoskeletal 
fitness by focusing on strength, balance, coordination, and flexibility in addition to 
greater adherence to the U.S. Dietary Guidelines are key lifestyle contributors 
associated with reduced CVD risk in otherwise healthy middle aged men. 
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CHAPTER ONE:  INTRODUCTION 
Cardiovascular disease (CVD) related mortalities have declined in recent years 
yet still remain the leading cause of mortality in modern societies (43).  CVD-
related deaths are associated with arterial dysfunction that, in part, is attributable 
to stiffening of large elastic arteries such as the aorta (92).  The underlying 
mechanism linking aortic stiffening to greater CVD risk is primarily due to 
increases in central pulse pressure, which elevates the myocardial oxygen 
demand and drives left ventricular hypertrophy (65).  In addition, an elevated 
central pulse pressure increases the time spent in systole and decreases the 
time spent in diastole.  Because coronary perfusion occurs during diastole, 
elevated central pulse pressure leads to reduced coronary perfusion (diastolic 
dysfunction) and ischemia (143).  Ultimately, arterial dysfunction accelerates 
heart failure by placing a greater strain on the heart, thus increasing CVD risk. 
Aging is the primary risk factor for CVD and is a critical component of arterial 
(aortic) stiffness etiology (92).  Additionally, aging negatively affects arterial 
function due to progressive increases in central blood pressure which over time 
cause repetitive and cumulative damage to vital structural proteins such as 
elastin (81).  When elastin for example begins to fragment and lose functionality, 
large elastic arteries (such as the carotids and femorals) cushion the ejecting 
blood from the left ventricle in a diminished capacity.  In order to accommodate 
the pathological arterial protein elastin, enhanced depositions of collagen can be 
seen throughout all layers of the artery, which is the body’s futile attempt to 
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preserve the cushioning effect that was lost with functional elastin (48, 130).  This 
pathophysiological process of ineffective stroke volume buffering, and structural 
remodeling is the consequence of vascular stiffening, determined by the “gold 
standard” measure of aortic pulse wave velocity (aPWV) (124).  Importantly, 
aPWV is a novel and powerful risk factor for CVD that predicts a first CV event 
after adjustment of traditional risk factors such as age, sex, diabetes, total and 
HDL cholesterol, smoking, and use of antihypertensive therapy (11). 
Understanding lifestyle correlates to arterial stiffness in an aging population 
would provide valuable insight into the types of behaviors that are associated 
with CVD risk.  For example, daily physical activity, fitness, body composition, 
and dietary quality.  The Center for Disease Control and Prevention 
recommendation to optimize CV health is relatively simple in its approach.  That 
is, engagement in physical activity and structured exercise through daily inclusion 
of aerobic and strength training modalities leads to maintenance and optimization 
of physical health.  While, in conjunction with physical activity and structured 
exercise, maximizing dietary quality by reducing empty calorie foods and 
increasing nutrient-dense whole foods, is of paramount importance for preserving 
overall physical health.  These two front-line, lifestyle approaches are usually 
recommended as a pair, and are vital for staving off the negative and pernicious 
effects of CVD such as arterial stiffness.  However, in the context of an aging 
population, it has not been established if physical activity, defined as total daily 
step counts, is directly related to aPWV.  Nor has it been established what 
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precise components of dietary quality are key for optimization of arterial health, 
structure, and function. 
 
Several studies have examined step counts as a measure of physical activity and 
identified correlations with arterial stiffness (3, 6, 9, 23, 38).  Although there are 
an array of validated methods to examine arterial stiffness, only aPWV is 
recognized as the gold-standard, and experts in the field have reached 
consensus on the predictive power and reproducibility of its measure (65).  As 
such, previously demonstrated correlations in the literature between step counts 
and arterial stiffness were either derived from measurements other than the 
aPWV, and from questionnaires that attempted to estimate – not directly 
measure – physical activity (61, 99). 
 
The relationship between physical activity and physical function is usually direct:  
If an individual increases daily physical activity, then he can increase the capacity 
to perform mechanical work.  A variety of strength and conditioning assessments 
of physical function attempt to quantify the work performed, usually in a 
movement-specific or time-dependent manner.  In short, being more physically 
active leads to an improved functional status for walking speed, leg strength, 
dynamic balance, modified push-ups, static back extension, and 
cardiorespiratory fitness in myriad adult populations (71, 107, 131, 133).  Yet, 
one physical function assessment, handgrip strength, has been shown to be 
equivocal in its relation to arterial stiffness. 
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Adherence to the U.S. Dietary Guidelines is associated with reduced CVD risk 
generally, due to maintenance of physical health through nutrient-dense foods, 
and reduction of empty calorie, refined, and sodium-rich foods.  However, there 
has been no study to date that has quantified and expressed overall dietary 
quality as one single metric, to determine whether adherence to the U.S. Dietary 
Guidelines is prophylactic.  The Healthy Eating Index (HEI) score is comprised of 
a multi-component model of human nutritional needs, and is a validated and 
reliable measure encapsulating overall dietary quality according to the U.S. 
Dietary Guidelines (46).  Expressing dietary quality as the HEI score is a strong 
predictor of CVD, all-cause mortality, and type-2 diabetes (121).  It would be 
worthwhile to represent the quality of an aging American population’s diet, and to 
associate with CVD risk such as large elastic artery stiffness. 
Furthermore, age-standardized risk of CVD is accelerated in men compared with 
women (80), indicating that there is a sex-specific relationship to the overall 
incidence and disease course of CVD risk.  The presentation of CVD in this 
relatively vulnerable population – a middle-aged male cohort – includes a 
stronger likelihood of abdominal aortic aneurysm, myocardial infarction, and 
unheralded coronary death (40). 
The purpose of this study was to examine lifestyle contributors to CVD risk in 
middle-aged men aged 30 to 60 years.  The hypotheses were that greater 
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physical activity and physical function are associated with reduced aortic stiffness, 
and 2) Higher dietary quality is associated with reduced aortic stiffness.
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CHAPTER TWO:  LITERATURE REVIEW 
The aging process accelerates vessel wall stiffening more than any one factor 
(142).  Age-driven stiffness of the arteries is arteriosclerosis, and is more 
pronounced in severity in the large elastic arteries (aorta, carotid) compared with 
the peripheral arteries (brachial, tibial).  As a consequence of biological aging for 
example, from early adolescence to middle adulthood (10 – 50 years of age) one 
can expect approximately a 70% increase in central arterial (aortic) stiffness; 
whereas, peripheral artery stiffness may only increase by ~20% (90).  Therefore, 
arterial stiffness is disproportionate in its development, and large elastic arteries 
such as the aorta, carotid, and femoral appear to harden more significantly than 
peripheral arteries such as the brachial, tibial, and radial arteries.  As such, the 
impact to cardiovascular health will vary throughout systemic circulation in a site-
specific manner.  
The detrimental effects of increased arterial stiffness are multifaceted, and 
complicated.  Although the discussion of these major three mechanisms will 
follow, arterial stiffness pathophysiology includes: 1) Increase in central systolic 
blood pressure; 2) Increase in left ventricular afterload; and 3) Decrease in 
diastolic perfusion pressure.  Primarily due to these physiological mechanisms, 
arterial stiffness is an independent risk factor for cardiovascular disease (CVD) 
that is associated with greater morbidity and premature mortality (11).  The gold-
standard measure of arterial stiffness is the carotid-femoral pulse wave velocity 
(cfPWV) (65).  In summary, arterial stiffness is a novel cardiovascular risk factor 
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that predicts incident CVD, and prospective data supporting the proposed 
pathophysiological mechanisms and their injurious consequences to 
cardiovascular health, are both mounting and convincing (11, 83, 84).  
Additionally, arterial stiffness accelerates target organ damage to the brain, heart, 
and kidneys (86).  Hence, understanding lifestyle factors that relate to arterial 
stiffness could provide a front-line protection strategy against an aging (and 
failing) cardiovascular system. 
To understand the pathophysiology of arterial stiffness, it would be important to 
briefly review the functional role of the arterial system.  The primary function of 
the arterial system is to provide oxygen and nutrient rich blood to the various 
tissues and organs of the body.  In addition, the arterial system, specifically the 
thoracic aorta, buffers the blood ejected from the heart by extending and recoiling 
to promote continuous blood flow in the capillaries (94).  This anatomical 
arrangement has been compared to windkessels of antique fire engines (69).  
Moreover, the ability to buffer the ejected blood from the heart is purposeful for 
cushioning the pulsatility during systole, and for steady downstream propagation 
of blood flow through the arterial tree during diastole.      
GENERAL PATHOPHYSIOLOGY OF ARTERIAL STIFFNESS 
When the left ventricle for example contracts, it creates what is referred to as an 
incident pulse pressure wave.  The pressure wave is the pulse.  This initial 
pressure wave is clinically relevant to study because aging augments the peak 
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systolic pressure wave and amplifies blood pressure.  Under normal, healthy 
physiological conditions the pulse pressure wave travels down the aorta and is 
partially reflected back to the heart while the remaining wave is transmitted to the 
microcirculation to promote low pulsatile capillary blood flow in tissues.  The 
return, or reflective wave arrives at the heart during diastole, which provides the 
driving pressure for coronary artery perfusion during relaxation.  When the aorta 
is stiffened, however, the pulse pressure wave moves more quickly through the 
vessel and a significant proportion of this wave will be transmitted to the 
microcirculation.  The increased pulsatility of the transmitted wave results in 
greater pulsatile blood flow in tissue capillaries and causes damage to small 
blood vessels. 
Moreover, the reflected wave as seen during aging will return to the heart sooner, 
during late systole when the heart is ejecting blood.  This leads to an increase in 
afterload (blood pressure at the aortic root), which the left ventricle must 
overcome to pump eject blood through the aortic valve.  This exact process is a 
contributing factor to hypertension, a traditional and established CVD risk factor.  
Additionally, the early arrival of the pulse pressure wave to the heart decreases 
the perfusion pressure in the coronary arteries, which reduces coronary blood 
flow at rest and during physiological stress such as exercise.  Thus, increased 
arterial stiffness – specifically aortic stiffness – is implicated in heart-related 
pathologies including myocardial ischemia, heart failure, and infarcts.   
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Increases in SBP, Pulse Pressure, and Afterload 
 
Arterial stiffness accelerates the return waves back to the left ventricle of heart, 
and elevates SBP and pulse pressure (systolic minus diastolic blood pressure).  
There is controversy regarding the causative factors of arterial stiffness.  In short, 
this relationship of arterial stiffness and elevated SBP (hypertension) has been 
compared to the informal chicken-and-egg dilemma (81).  The current general 
viewpoint is that hypertension in young adults accelerates arterial stiffness that is 
similar in severity to that of aging, due to the premature return and magnitude of 
the reflected waves occurring in late systole (65).  Notwithstanding, there is 
evidence indicating arterial stiffness precedes the rise in blood pressure seen in 
hypertensive adults (81).  In any regard, an increase in SBP gives rise to a 
stressed and over-worked myocardium, which has to increase oxygen 
consumption to overcome the afterload.  In summary, increases in SBP, pulse 
pressure, and afterload signify arterial stiffening that is associated with left 
ventricular hypertrophy (LVH) (15, 73).  LVH is an established risk factor for CVD 
prospectively linked to premature mortality and increased morbidity (15, 42, 90, 
112). 
 
Decrease in Coronary Perfusion Pressure 
 
Isolated systolic hypertension is characterized by a normal diastolic blood 
pressure (DBP), but with a systolic pressure greater than 140 mmHg.  Because 
the vast majority of the myocardial blood flow occurs during diastole, sufficient 
and robust coronary perfusion pressure is required to oxygenate the heart.  
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Interestingly, DBP increases with age up until approximately 60 years, and then 
decreases (114).  Because arterial stiffness increases dramatically after 60 years 
of age, the fall in DBP with increasing arterial stiffness is explained by a 
diminished hydraulic buffering system.  Recall that the principal function of large 
elastic arteries is to cushion the blood as it is ejected from the heart.  Yet, with 
arterial stiffness, the capacity to “hydraulically” buffer is severely diminished, 
leading to greater peripheral “run-off” of stroke volume during systole (114).  
Results from the Framingham study, for instance, indicate elevated DBP is also 
associated with increased SBP, which allows arterial stiffness to perpetuate in an 
accelerated and vicious cycle (37).  Collectively, these findings indicate that 
greater arterial stiffness in older age reduces coronary perfusion pressure, which 
is prospectively linked to myocardial ischemia, infarcts, unstable angina, and 
premature mortality. 
 
MEASURING ARTERIAL STIFFNESS IN ADULT POPULATIONS 
 
The changes within arteries leading to age-related arterial stiffening are largely 
due to functional and structural changes within the artery (90).  These arterial 
changes result in volume and pressure changes, which can be assessed as 
indicators of arterial stiffness.  For example, to determine the compliance, or 
elasticity of an artery one can quantify the changes in volume and pressure 
(compliance = ∆V/∆P) during a cardiac cycle.  Pulse pressure can also be easily 
assessed clinically and used as a surrogate measure of arterial stiffness.  To 
gain even greater insight, however, Young’s modulus, a ratio of force per unit 
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area (stress, units = Pa) per unit length (strain, ratio of the deformation to its 
original form, units = dimensionless), has also been used to characterize arterial 
wall stiffness using the incremental elastic modulus (Einc). The Einc can then be 
used to calculate pulse wave velocity (PWV) as described in the Moens-Kortweg 
equation: PWV = √(Einc • h / 2 r ρ), where h is the vessel wall thickness, r is the 
vessel radius, and ρ is the density of blood.  In brief, aging increases arterial 
stiffness (measured as PWV), which can be assessed throughout the arterial tree 
in a site-specific manner (90). 
 
Pulse Wave Velocity 
 
The viscoelastic properties of arteries vary widely across the arterial tree.  
Because of this, extrapolating segmental arterial properties and making 
conclusions about the entire arterial tree is not prudent (65).  However, local 
and/or regional measures, of arterial stiffness of large elastic arteries can be 
assessed non-invasively, using ultrasonic echotracking systems, magnetic 
resonance imaging (MRI), or by using the pulse pressure wave that is generated 
with each contraction of the heart (65).  The velocity of the pressure wave also 
varies across the arterial tree, such that, the velocity of this pressure wave is 
lower in the proximal aorta than in the periphery indicating the aorta is less stiff 
than peripheral arteries (69).  Consequently, when arterial stiffness is high, as in 
aging, so is the PWV.  The pressure wave can be conveniently palpated at the 
radial, femoral, or carotid arteries for routine and repeatable measurements.   
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To determine regional arterial stiffness of the aorta, which includes the entire 
aorta except the ascending segment, non-invasive carotid-femoral pulse wave 
velocity (cfPWV, also called aortic pulse wave velocity = aPWV, used 
interchangeably) can be utilized as it is considered the ‘gold-standard’ 
measurement (65).  To obtain this measure the pulse waveforms are acquired 
non-invasively, either sequentially or simultaneously, at the carotid and femoral 
arteries using tonometry or Doppler flow probes relative to the R wave of the 
same left ventricular depolarization event.  The superficial distance (D, meters) 
between the right common carotid and right femoral arteries, and the time delay 
(∆t or transit time, seconds) between the feet of the two respective waveforms 
are acquired.  By measuring the distance between the carotid and femoral 
arteries relative to the suprasternal notch, a reference point, height is accounted 
for in this measurement. cfPWV/aPWV is therefore calculated as D (meters) / ∆t 
(seconds), which provides a regional measure of aortic stiffness.  Logically, the 
greater the velocity of the pulse wave traveling down the aorta the greater the 
extent of arterial stiffening.  Importantly, this ‘gold-standard’ measure of arterial 
stiffness is associated with cardiovascular events, independently of conventional 
risk factors (94).   
PULSE WAVE ANALYSIS 
Applanation tonometry is a technique used to assess central hemodynamic 
parameters that can influence arterial stiffness.  There are many commercially 
available devices, but the SphygmoCor system (AtCor Medical, West Ryde, 
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Australia) is one of the most widely used and validated devices.  The 
SphygmoCor cardiovascular measurement system uses a generalized 
mathematical transfer function to create an aortic pressure waveform that is 
computed both from the pressure waveform at the radial artery and brachial 
blood pressure.  The Food and Drug Administration has accepted the central 
blood pressure values derived from peripheral waveforms via applanation 
tonometry as a “substantially equivalent” assessment of aortic pressure when 
compared with invasive catheterization measures (94).  Hence, applanation 
tonometry is a validated, non-invasive alternative to catheterization and is 




Central hemodynamics, which is blood pressure measured at the central (aortic) 
level, is a stronger predictor of incident CV events than peripheral (brachial) 
blood pressure (153).  Therefore, determining central hemodynamic variables 
such as SBP, DBP, PP, and MAP, the researcher is able to take a biomedically 
worthwhile screen for CVD risk in aging adults.  Clinically, blood pressure is 
typically measured in the arm at the brachial artery, thus constituting a 
“peripheral” measure of hemodynamics.  Blood pressure measured at the aortic 
level, however, is a vital component of “central” hemodynamics and this central 
(aortic) location is increasingly being used for cardiovascular risk assessment 
due to its predictive value over and above brachial derived (peripheral) blood 
pressure (153).  Again, current research indicates that central, not brachial, 
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hemodynamics is a stronger predictor of a first CV event, thus making central 
blood pressure values biomedically and societally relevant (153).  One example 
of the discrepancy between the central and peripheral vasculature is the 
amplification phenomenon, which follows that pulse pressure is lower in the aorta 
compared with brachial artery.  Yet, in conditions of aging, pulse pressure 
amplification is decreased due to increases in aortic stiffness and blood pressure.  
Central (aortic) hemodynamic parameters such as pulse pressure can be 
accurately and easily obtained with tonometry; furthermore, quartiles of central 
pulse pressure are stronger predictors of future CV events in contrast to quartiles 
of peripheral pulse pressure (111).  Clinicians have historically relied on and 
continue to use peripheral blood pressure measures to determine treatment 
options.  But, there are numerous data suggesting treatments based on central 
blood pressures may be more effective at identifying elevated CVD risk in adult 
populations (14, 33, 127). 
 
Central Pulse Pressure 
 
Pulse pressure, or the difference between systolic and diastolic blood pressure 
within arteries is an important surrogate marker for arterial stiffness. Based on 
the pressure-strain elastic modulus, Ep to define arterial stiffness, which is 
calculated by the equation Ep = ∆P / (∆D/D), where ∆P is the aortic pulse 
pressure; ∆D is the maximal change in aortic diameter during the cardiac cycle; 
and D is the mean aortic diameter during the cardiac cycle.  This described 
characterization of arterial stiffness points to elevated central pulse pressure as a 
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major participant in the disease’s etiology. Ultimately, the pressure-strain elastic 
modulus will be elevated in individuals whose aorta is unable to increase luminal 
diameter for a given pressure.  Hence, pulse pressure is the pulsatile component 
of blood pressure that drives repetitive strain and contributes to fragmentation of 
aortic elastin, which can be used as a surrogate marker of arterial stiffness (81). 
It is important to consider within the context of enhancing cardiovascular risk 
prediction, that the routine use of central pulse pressure measurements in clinical 
practice has not been substantiated (82).  
 
Pulse Pressure Amplification 
 
The pulse pressure wave increases in amplitude as it travels away from the heart.  
To ascertain the pulse pressure amplification percentage, divide the central 
(aortic) pulse pressure into the peripheral (brachial) pulse pressure, and multiply 
by 100.  This value is of clinical interest because the widening gap in pulse 
pressure between central vs. peripheral arterial locations indicates the presence 
of aortic stiffness (8).  Great debate exists as to whether central or brachial blood 
pressure, or both, should be derived and reported clinically.  Because aging is 
the principal determinant of the reduction in pulse pressure amplification (101), 
the interaction between central and peripheral blood pressure is an important 





Augmentation Index (AIx) 
 
AIx is the difference between the first and second systolic peaks relative to pulse 
pressure (65).  The AIx measure is based on the return, or reflected, wave that is 
transmitted with each heartbeat. In arteries that confer greater stiffness the 
reflected wave returns to the left ventricle of the heart sooner causing 
amplification of the systolic blood pressure.  The early arrival of the reflected 
wave increases the myocardial oxygen demand and requires greater mechanical 
work to overcome the augmented aortic root pressure (afterload), which is one 
deleterious consequence of arterial stiffness. AIx has also been used as a 
surrogate measure of arterial stiffness (81). 
 
While the interpretation of AIx is straightforward, one limitation of using this 
measure as a substitute of cfPWV is AIx has a nonlinear relation with arterial 
stiffness with increasing age (149).  After approximately 60 years of age AIx 
drops, but arterial stiffness when measured by the cfPWV, increases (76, 85). 
Therefore AIx is considered to be a more global, or whole-body, measure of 
stiffness, rather than a specific aortic stiffening endpoint as it assesses the 
cumulative reflected waves at the heart.  AIx may be used to describe the 
magnitude of peripheral wave reflections, but care should be taken when using 
AIx as a measure of arterial stiffness, particularly in older populations.  Moreover, 
due to the dependence on heart rate, it is important to standardize or normalize 
the augmentation index to pulse pressure at a specified heart rate.  Many 
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common medical devices have an in-built feature that adjusts the augmentation 
index to a heart rate of 75 beats per minute. 
Subendocardial Viability Ratio (SEVR%) 
During a normal cardiac cycle, the percentage of time spent in diastole is 
approximately 67% (two-thirds).  Recall that coronary blood supply occurs during 
diastole, when the demand for oxygen is high.  However, during overt CVD the 
myocardium spends progressively more time in systole, in an effort to overcome 
the exaggerated afterload within the aortic root, and so the time spent in diastole 
is markedly decreased.  Logically, this manifestation of CVD will lead to 
enlargement of the left ventricle, and ultimately heart failure.  Hence, a marker of 
diastolic function has been established to represent the time spent in diastole 
divided by the time spent in systole.  Aging, low cardiorespiratory fitness, and 
central obesity are strong (negative) predictors of the Buckberg ratio, or the 
SEVR% (16). 
GLOBAL CONTRIBUTORS TO ARTERIAL STIFFNESS 
Aging 
In the United States, the proportion of patients greater than 65 years of age is 
increasing at a greater rate than the total population (144).  Importantly, the 
primary determinant of cardiovascular health is age (92).  Therefore 
understanding the impact of early, accelerated and/or heightened vascular aging 
are important initial steps for identifying vulnerable older populations. For 
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instance, during ‘normal’ arterial aging there are functional, structural, and 
cellular and molecular events, which collectively results in arterial stiffness.  
However, individuals where the arterial aging process is accelerated beyond 
what would be expected in a normal or reference population, additional increases 
in aPWV will be observed indicating greater CVD risk (63). Identifying the 
physiological mechanisms promoting age-related arterial stiffness and the 
accelerating factors contributing to greater CVD risk are thus clinically significant. 
 
The Baltimore Longitudinal Study on Aging (BLSA) is a large prospective cohort 
study that assessed aPWV over a period of 7 years in a subset of 943 
participants (2).  Both older age and increased systolic blood pressure (SBP), or 
hypertension in this population, were the main longitudinal determinants of age-
related increases in aPWV.  Furthermore, the effect of SBP on the rate of 
increase in aPWV was evident even in prehypertensive subjects, and was 
associated with an accelerated rate of aPWV in a dose dependent manner.  The 
isolated impact, however, of elevated SBP on arterial stiffness is difficult to 
partition and remains a current challenge. Notwithstanding, it has been shown 
that after controlling for traditional cardiovascular risk factors, including blood 
pressure, an increase in 5 m/s of aPWV is equivalent to aging 10 years, in terms 
of increased likelihood of CVD mortality (64). In very old populations (ie 70 to 100 
years), aPWV is a strong independent predictor of cardiovascular mortality with 
an adjusted odds ratio of 4.60 (95% CI, 1.4 to 15.7) when aPWV was >17.7 m/s 
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(77). Thus, it is evident that both aging and even modest increases of SBP in 
older adults are primary factors in greater CVD risk in older populations.  
 
To further highlight the influence of age on aortic stiffness in a large healthy 
normotensive population (age range = 18 to 90 yrs), it was shown that aPWV 
beyond 50 years increases at an accelerated rate (76). Therefore, the data 
suggest arterial stiffness is a more sensitive marker of vascular aging in older 
compared with younger adults. Hence, in this study, the relationship between 
arterial stiffness showed an exponential increase after the 5th decade of life, and 
the inclusion of age as a predictor of aPWV accounted for 60% of the total 
variance. Similarly in another study, after controlling for gender, body size, and 
heart rate, aPWV increased by 1.56 m/s per 10 years from age 20 to 80 years in 
which a marked trend occurred after 50 years of age (109).  
 
Notably, in the presence of obesity and diabetes, arterial stiffness increases 
more rapidly with advancing age, which would be equivalent to a 70 year old 
adult (41, 83). These findings provide additional insight for age as the primary 
factor influencing arterial stiffness, which is accelerated at ~50 years of age, and 
for both obesity and diabetes as contributors to accelerated age-induced aortic 
stiffness.  Further, the National Institute on Aging SardiNIA study, a population-
based, follow-up study involving more than 4,000 community-living men and 
women (age range = 20 to 100 yrs) showed that aPWV increased by ~60% from 
age 30 to 70 years (123).  An additional cross-sectional study using 102 Korean 
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adults (age range = 21 to 60s yrs) demonstrated that aging accounted for 37% of 
the total variance of arterial stiffness, which increased by 0.07 m/s per year (72).  
In summary, arterial stiffness increases linearly until approximately 50 years of 
age, after which time there is an acceleration of the stiffening process.  
Cardiorespiratory Fitness 
Aging is the strongest predictor of arterial stiffness for both women and men.  
Chronic, regular physical activity can blunt the age-related arterial stiffening, as 
indicated in physically active older adults with similar aPWV compared to middle 
aged adults (136).  However, a significant difference in aPWV was still observed 
between groups indicating regular activity cannot fully reverse the age-related 
increase in arterial stiffness to those of younger adults.  The strongest predictors 
of aPWV in this cohort were cardiorespiratory fitness (ie VO2peak) and total and 
LDL cholesterol, which collectively explained up to 50% of the variance in central 
arterial stiffness (136).  Similarly, VO2peak has been shown to be associated with 
reduced PWV and body fatness, and greater amounts of regular physical activity 
in an apparently healthy middle aged adults (155). In addition, an important 
mechanistic relationship was shown in older but not younger adults between 
VO2peak and relative left ventricular wall thickness (R = -0.32, P < 0.05), indicating 
that more favorable cardiac remodeling is predicated on greater cardiorespiratory 
fitness.  In brief, greater physical activity and improved cardiorespiratory fitness is 
associated with reduced arterial stiffness and more favorable cardiac remodeling 
in middle-aged and older women.  
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Men with higher cardiorespiratory fitness also demonstrate reduced arterial 
stiffness, in part, through reductions in resting heart rate (104). In addition, it has 
been shown that men who engage in regular endurance exercise had lower 
aPWV than both resistance trained and sedentary (non-exercising) participants 
(96).  This relationship of reduced arterial stiffness was dependent on greater 
cardiorespiratory fitness, reduced SBP, and reduced endothelin-1, a 
vasoconstrictor, in the endurance trained men (96). Importantly, it has also been 
demonstrated, for both men and women, greater cardiorespiratory fitness and 
reduced arterial stiffness is associated with improved occipitoparietal perfusion 
and better cognitive composite scores (memory and attention-executive function) 
than those with lower cardiorespiratory fitness and greater arterial stiffness (138). 
Thus, suggesting cardiorespiratory fitness and reduced arterial stiffness may 
influence important cognition centers in the brain.  Collectively, these data 
indicate chronic exercise and/or increased cardiorespiratory fitness in men and 





Regular, progressive strength training is an important exercise modality for 
preserving the aging associated decrements in lean muscle mass, strength, and 
physical function.  However, reports have suggested strength training may 
increase measures of arterial stiffness.  For example, Bertovic et al. (13) 
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compared apparently healthy young males who had regularly strength trained for 
12 months to sedentary controls, and discovered that strength trained athletes 
had higher aortic characteristic impedance (defined as the pressure change 
generated by a given flow wave change in the absence of reflections) and β 
stiffness.  Additionally, strength trained athletes had greater carotid and brachial 
pulse pressures compared with the sedentary controls (13).  Similarly, young 
men (age range = 20 – 38 yrs) who engaged in resistance training for 4 months 
increased β stiffness and decreased carotid arterial compliance.  These positive, 
structural changes were inversely related to alterations in left ventricular mass 
and hypertrophy indices (87).  Interestingly, detraining from resistance-based 
exercise reversed the negative impact of strength training on arterial compliance, 
as arterial stiffness values returned to baseline after 4 months of detraining (87).  
Last, it has been shown that young men (age = 21 yrs) who had been strength 
training for 2 years had greater aPWV, and increased plasma endothelin-1 levels, 
compared with endurance trained athletes and sedentary controls (96). 
Additionally, in middle aged men, strength trained vs. sedentary controls had 
greater β stiffness, SBP and MAP, indicating that resistance-based exercise 
promotes arterial stiffening.  Whereas, vasoreactivity to a sympathetic stimulus 
was similar between the strength trained vs. sedentary controls, indicating 
endothelial function remains intact despite changes to other measures of large 
elastic artery function (60).  In short, there is convincing evidence that strength 
training increases arterial stiffness in both young and middle aged men. However, 
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it is important to note that strength training is a recommended form of exercise to 
prevent age-related decreases in muscle mass, and that concomitant aerobic 
exercise offsets the influence of strength training on arterial stiffness (24, 79). 
Undeniably, strength training per current guidelines in conjunction with aerobic 




The association of increased step counts and reduced arterial stiffness has been 
shown in children (115) and diseased adult populations with hypertension (93) 
and type-2 diabetes (57).  Moreover, the identical association persists in older 
adults (6, 38, 66).  However, in a middle-aged population one significant 
confounding variable is gender.  Given that several investigations have shown an 
inverse relationship between physical activity and arterial stiffness in both male 
and female subjects (3, 44), it would be worthwhile to isolate gender, and 
determine if more total physical activity is associated with arterial stiffness.   
 
There are several validated and reliable methods to measure local, regional, and 
global arterial stiffness.  Yet, the gold-standard method is the pulse wave velocity.  
In order to accurately characterize the influence of physical activity on arterial 
stiffness, directly measuring step counts and correlating with the aortic pulse 






In young men, an inverse relationship between muscular strength and arterial 
stiffness was demonstrated independent of aerobic fitness (34).  Physical 
function is essentially “what the human body can do” and is important for 
activities of daily living and maintenance of physical independence that is crucial 
during older years.  The use of hand-grip strength as a measure of function 
(strength) is associated with lean muscle mass both in young populations as well 
as older ones (116), and is associated with old age disability (105).  However, to 
date, no study has examined an otherwise apparently healthy middle-aged 
population to determine if the relationship between handgrip strength and arterial 
stiffness remains.  To speculate, the association of reduced physical function and 
greater arterial stiffness may be due to a phenotypic shift in skeletal muscle.  For 
example, when muscle contracts regularly as it does during regular aerobic and 
anaerobic exercise, the secretome changes in a favorable way.  However, when 
sedentary time is increased and an individual does not move or exercise 
regularly, the secretome is unfavorably changed in a way that may negatively 
interact with the vasculature.  One example is an increased in pro-inflammatory 
cytokines that communicate in a paracrine manner with the large arteries, thus 
leading to greater CVD risk as a result of insufficient skeletal muscle contractions. 
 
In general terms, accumulation of regular physical activity leads to improved 
cardiorespiratory fitness, which is a health-related component of physical function 
(107).  More specifically, regular physical activity is associated with 
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improvements in musculoskeletal tests such as modified push-ups, static back 
extension, and the one-leg standing balance test in an apparently healthy middle-
aged adult population (133).  Regarding older adults, improved 400 meter 
walking speed and time is associated with reduced arterial stiffness (45).  And, 
greater physical activity is associated with delayed disability retirement due to 
maintenance of musculoskeletal health (62) such as lower body strength (71) 
which plays a crucial role in the prevention of functional decline with advancing 
years and decreasing physical activity (39).  Thus, achieving greater amounts of 
physical activity directly and positively impacts the functional state of 





Assessment of body composition, particularly body fatness, and relating to 
measures of arterial stiffness is critical. However, there are many facets, and 
limitations for the different measures of body composition that need to be 
considered prior to discussing body composition and arterial stiffness. For 
example, fat and fat-free mass can be assessed by dual energy x-ray 
absorptiometry (DXA) and computed tomography (CT) scans that provide valid 
measures. Both DXA and CT scans are preferable measures; however, they are 
costly and are not always feasible for larger population studies. For larger studies, 
body mass index (BMI) is a common measure of total body fatness, which is 
determined with the ratio of weight (kg) to height (m2). As such, BMI quantifies 
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total mass, and does not selectively quantify fat or fat-free mass. Hence, 
individuals who have a high BMI may not necessarily have a high body fat 
percentage, but instead could have a large amount of fat-free mass that could 
increase BMI but not reflect greater fat mass. In large part, however, BMI is a 
standard and valid method for assessing body fatness in sedentary and 
recreational active individuals, or those without large amounts of muscle mass.  
 
Greater fat mass resulting in obesity has been implicated in arterial stiffness 
across the lifespan. As such, overweight and obese adolescents (n = 86; BMI ≥ 
85th percentile) demonstrate a higher aortic and brachial SBP and PP, and mean 
arterial pressure (MAP), than adolescents of normal weight (n = 141; BMI < 85th 
percentile) (102).  Moreover, overweight/obese adolescents have a 7% higher 
aPWV and 3.5% lower PP amplification than the adolescents of the normal 
weight group (102).  It is particularly worrisome and likely that, given the negative 
implications of childhood obesity on arterial function, overweight and obese 
adolescents will carry unhealthy juvenile behaviors into adulthood that will give 
rise to early CVD risk.  For instance, it has been shown in a large follow-up study 
that childhood body size or adiposity was associated with increased intima-media 
thickness and large artery stiffness as an adult (55). Thus, it is imperative to 




Overeating, or excessive caloric intake, and/or a sedentary lifestyle contribute to 
weight gain and obesity. When normal weight, non-obese adults were overfed for 
6 to 8 weeks by ~1000 kilocalories/day (5 kg of weight gain), total abdominal fat, 
abdominal visceral fat, and waist circumference increased in parallel with arterial 
stiffness by 13% (95).  These findings were similar in Amsterdam Growth and 
Health Longitudinal Study, in which they found that an increase of trunk mass by 
10 kg was positively associated with carotid Young’s elastic modulus (120). In 
short, the magnitude of abdominal visceral fat accumulation appears to be an 
important contributor of large artery stiffening in adults (95, 132). 
In addition to short-term weight gain, chronic obesity in adults results in 
significant metabolic burden due to excessive fat storage, and ultimately, a 
clinical manifestation of arterial dysfunction. In large part, overweightness and 
obesity are considered to be important in arterial stiffening (4, 91, 95).   
Contrary to this notion, it has been asserted that BMI is not very useful in 
predicting changes in arterial stiffness due to generalized obesity (152), and that 
the cardiovascular system of older adults may display an adverse association of 
body fat and arterial stiffness in contrast to young adults who may be more 
adaptable to the state of obesity (26).  Waist circumference, in fact, was the only 
measurement positively associated with early atherosclerosis and arterial 
stiffness in the Supplementation en Vitamines et Mineraux Antioxydants 
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(SU.VI.MAX) study, in which over 1,000 middle-aged adults were assessed for 
body composition and carotid structure and function (28). 
 
In support of this finding, older adults from the Health ABC study demonstrated 
an association of aPWV and abdominal visceral fat (the strongest predictor of 
arterial stiffness) that was consistent across tertiles of body weight (134).  
Additionally, older men with high amounts of total lean mass and low total fat 
mass exhibited the most favorable arterial profile, including reduced aPWV (12).  
For older women, greater trunk fat mass was the strongest predictor of arterial 
stiffness (35). Although general obesity does contribute to arterial stiffness for the 
population at large, some studies indicate abdominal obesity is a better predictor 




A recent population-based investigation, the Maine-Syracuse Longitudinal Study, 
examined older men and women for lifestyle habits that relate to arterial stiffness, 
including diet quality (27).  The significant relationship demonstrated with the 
“recommended food score” and arterial stiffness indicates that the overall quality 
of one diet is directly related to CVD risk.  These results may not be applicable to 
individuals beyond the study population.   In other words, because the composite 
cardiovascular health scores were grouped in tertiles, the central limitation of this 
study is that the results of the nutritional questionnaire were not correlated with 
aPWV.  Using a more robust, validated and reliable measure of overall dietary 
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quality would allow for insight into the specific components of human nutrition 
that are associated with arterial stiffness. 
 
The Healthy Eating Index (HEI) is a valid and reliable measure of diet quality and 
determines adherence to the 2010 U.S. Dietary Guidelines for Americans (46).  
Compliance with the U.S. Dietary Guidelines is favorably associated with 
vascular health, including reduced arterial stiffness (119).  Further, diets that 
score high on the HEI are associated with reductions in all-cause and CV-related 
mortality (121).  Thus, the HEI score, a summated twelve component index of 
long-term (1 year) diet quality and food frequencies and preferences, provides 
more direct and specific insight into the exact dietary components associated 
with reduced arterial stiffness.  
 
For instance, previous research has shown that the ratio of unsaturated to 
saturated fatty acid consumption is an important determinant of preserved 
cardiovascular health including arterial function and stiffness (49).  Additionally, 
consumption of low-fat compared with whole-fat dairy was negatively correlated 
to the aPWV in 20 to 80 year old men and women (108).  Further, greater fruit 
and vegetable consumption are inversely associated with arterial stiffness, even 
in young adulthood (1).  It remains to be seen whether overall dietary quality is 




KEY NUTRIENTS AND FUNCTIONAL FOODS 
 
The role of dietary factors in both the acceleration and slowing of CVD is 
undeniable.  Skewing the energy balance equation towards greater intake vs. 
expenditure is the principal cause of obesity, which in turn accelerates arterial 
stiffening and the risk of CVD events. Understanding the impact of food intake, in 
terms of quality and quantity, and how it relates to CVD is a 21st century puzzle 
that remains to be solved.  Many so-called “heart healthy” diets that have been 
conventionally recommended such as reduced saturated fat intake have shown 
poor associations with overall CV health status, thus complicating matters (29).  
It now appears as though the relation of saturated fat intake to CVD risk is 
dependent upon the source, be it plant or animal based (10, 29).  To date there is 
no consensus as to what exactly a “heart healthy” diet should consist of, and if in 
fact saturated fat intake is as pernicious as once thought. 
 
Omega-3 Fatty Acids 
 
Over the last 50 years studies have shown an array of health benefits among 
those following Mediterranean diets, including reduced CVD risk (122).  Several 
advantages of following a Mediterranean diet is improved vasodilation, 
decreased blood pressure, and reductions in oxidative stress and inflammatory 
biomarkers (146).  The purported mechanism of reduced CVD risk by the 
Mediterranean diet is due to the greater intake of long chain polyunsaturated 
omega-3 fatty acids.  The plant based food sources of omega-3 fatty acids (alpha 
linolenic acid [ALA]) include flaxseed, hempseed, soybeans, and walnuts (117, 
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146).  The marine sources of omega-3 fatty acids (eicosapentaenoic acid [EPA] 
and docosapentaenoic acid [DHA]) include algae, salmon, mackerel, and trout.  
Importantly, the metabolic conversion of the 18 carbon fatty acid ALA to the 20 
carbon fatty acid EPA and 22 carbon fatty acid DHA is approximately 5% in 
humans, thus making it “essential” to consume EPA and DHA in copious 
amounts (17). In short, specific consideration should be given to the type of long 
chain polyunsaturated omega-3 fatty acid consumed, in particular EPA and DHA, 
due to their association with decreased CVD risk factors and improved vascular 
outcomes (18). 
 
Unfortunately, the metabolic syndrome is a common disease, characterized by at 
least three of the following risk factors: abdominal obesity, low HDL cholesterol, 
high triglycerides, hypertension, and impaired fasting glucose.  The metabolic 
syndrome accounts for up to 1/3rd of CVD in men (151), therefore assessing the 
influence of omega-3 fatty acids in a metabolic syndrome population is a 
promising therapy. As such, 12 weeks of oral supplementation with 2 g/day of 
omega-3 polyunsaturated fatty acids (46% EPA; 38% DHA) in middle-aged 
adults with metabolic syndrome reduced aPWV from 7.62 ± 1.59 at baseline to 
7.22 ± 1.54 m/s (P < 0.001) at the end of the trial.  Additionally, total cholesterol, 
triglycerides, LDL cholesterol, and IL-6 were significantly reduced, while 
plasminogen activator inhibitor 1 and flow mediated dilation increased, over the 
course of the 12-week intervention compared to baseline values (P < 0.001).  
The favorable effects of omega-3 supplementation on endothelial function and 
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arterial stiffness in adults with metabolic syndrome appear to be partially 
mediated through modification of the metabolic profile and inflammatory 
processes (140).  
 
As mentioned previously, endothelial dysfunction is an early event in the 
pathogenesis of arteriosclerosis that increases CVD risk.  Cigarette smoking is 
associated with dose related and (potentially) reversible impairment of 
endothelium dependent arterial dilation in asymptomatic young adults (22). The 
smoking related impairment in endothelium dependent arterial dilation promotes 
increases in the pro-inflammatory phenotype, leading to changes in the 
thrombosis/fibrinolysis system, which are important pathways for coagulation and 
the enzymatic breakdown of blood clots (5).  In a randomized, placebo-controlled, 
double-blind, and crossover study, the effects of 12-week omega-3 
polyunsaturated fatty acids supplementation (46% EPA; 38% DHA) in 20 healthy 
smokers (13 males; 7 females; mean age = 28 ± 3 yrs) who had been smoking 
greater than 20 cigarettes per day for greater than 5 years were determined 
(128).  Treatment with omega-3 polyunsaturated fatty acids reduced aPWV from 
5.87 ± 0.63 at baseline to 5.54 ± 0.76 m/s (P = 0.007) following the intervention.  
Additionally, TNF alpha and IL-6 were significantly reduced, while plasminogen 
activator inhibitor 1 and flow mediated dilation increased, over the course of the 
12-week intervention compared with baseline values (P < 0.05). Supplementation 
with omega-3 fatty acids did not, however, influence the lipid profile.  In short, the 
detrimental effects of regular cigarette smoking on endothelial function and 
 33 
elastic properties of the arterial tree can be ameliorated by long chain omega-3 
fatty acids such as EPA and DHA in asymptomatic adults, in part, through 




The consumption of highly salted food is increasing worldwide, and these 
changes in salt intake present a major challenge on the physiological systems of 
the body (50).  Much evidence exists regarding our high salt intake and its role in 
creating the large rise in blood pressure that occurs with age (50).  Therefore, 
minimizing sodium intake has been an important strategy for addressing the age-
associated increase in blood pressure, which is directly linked to the 
pathophysiological processes that underpin arterial stiffness.  For example, 
Dietary Approaches to Stop Hypertension (DASH) have been successful in 
reducing systolic and diastolic blood pressures in a variety of adult populations, 
and so DASH-like diets that invoke these beneficial effects of reducing blood 
pressure and the concomitant decrease in arterial stiffness are highlighted in this 
subsection (118). 
 
In a randomized, placebo-controlled study with a crossover design, eight men 
and three women (mean age = 60.2 yrs) with moderately elevated systolic blood 
pressure (139 ± 2 / 83 ± 2 mmHg) followed a low sodium (77 ± 99 mmol/day) or 
normal sodium (144 ± 7 mmol/day) diet for five weeks (56).  aPWV for the low 
sodium condition was significantly reduced compared to that of the normal 
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sodium condition (7.0 ± 0.4 vs. 8.43 ± 0.36 m/s, P = 0.001).  Furthermore, 
systolic blood pressure was significantly reduced as a result of the low sodium 
condition compared with baseline and the normal sodium condition (low sodium: 
127 ± 3, baseline: 139 ± 2, normal sodium: 138 ± 5, P < 0.001).  
 
It is important to consider that systolic blood pressure is a key determinant of 
large elastic artery (aortic) stiffness (59), which may explain the impact of low 
sodium consumption on reductions of aPWV in this middle-aged and older cohort 
of adults with moderately elevated systolic blood pressure.  
Similarly, a study in a postmenopausal cohort of women of middle and older age 
(n = 17; mean age = 65 ± 10 yrs) used a three-month sodium restriction protocol 
(pre-intervention to post-intervention: 2685 ± 559 vs. 1421 ± 512 mg/day) to 
assess changes in arterial function (125).  In addition to reductions in systolic 
blood pressure (~16 mmHg, P < 0.05), aPWV was also significantly reduced as a 
result of three months of sodium restriction (8.7 ± 2.0 vs. ~7.3 ± 1.1 m/s, P < 
0.05). Again, this study highlights the influence of blood pressure reduction with 
sodium restriction to decrease central arterial stiffness in women whose systolic 
blood pressure ranged from 130 – 159 mmHg. 
 
Additional studies have also demonstrated reductions in blood pressure and 
arterial stiffness in mildly hypertensive patients (n = 169; mean age = 50 ± 11 yrs; 
147 ± 13 / 91 ± 8 mmHg) as a result of modest sodium restriction (51). In this 
study, the reduction in salt intake from 9.7 to 6.5 grams/day was successful in 
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reducing systolic blood pressure by 5 ± 12 mmHg (P < 0.001).  Importantly, 
aPWV also dropped from 11.5 ± 2.3 to 11.1 ± 1.9 m/s, which was statistically 
significant (P < 0.01).  These results demonstrate that a modest reduction in salt 
intake can improve CVD risk by attenuating systolic blood pressure and 
increasing compliance of the aorta.  Because the reduction in salt intake was in 
accordance with current public health recommendations, the improvements 
(albeit slight) seen in arterial stiffness are promising not only for mildly 
hypertensive adults, but also normotensive adults.  The research regarding 
sodium restriction in well-controlled clinical trials is undoubtedly scarce.  However, 
the studies presented herein point to a meaningful connection between sodium 
consumption, systolic blood pressure, and arterial stiffness that deserves further 
clarification. 
 
Antioxidant Vitamins (C and E) 
 
It has been hypothesized that vascular function and structure will be improved if 
oxidative stress can be ameliorated by reducing free radicals and protecting nitric 
oxide (NO) from inactivation (68).  Supplementation with antioxidant vitamins C 
and E, in particular, are recognized to protect against lipid peroxidation, a 
contributor to arterial stiffness.  And many observational studies have shown that 
a high dietary intake or high blood concentrations of antioxidant vitamins are 
associated with reduced risk of CVD in general (126).  Yet few studies have 
examined the potential effects of antioxidant supplementation on vascular 
stiffness and function in humans. 
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Using an emulsified preparation of a tocotrienol-rich vitamin E supplement, 36 
healthy young men (mean age = 23.9 ± 0.39 yrs) were assigned to either 50, 100, 
or 200 mg daily supplementation of this compound for eight weeks (106).  All 
treatment groups had higher plasma concentrations of vitamin E following the 
eight-week study duration (P < 0.05).  Vitamin E supplementation had no effect 
on systolic blood pressure. However, aPWV was significantly reduced in both the 
100 mg and 200 mg supplementation groups by 0.77 m/s and 0.65 m/s, 
respectively.  This reduction in aortic stiffness was approximately 10% less than 
the values observed at baseline.  Mechanistically, it has been shown that free 
radicals inactivate endothelium derived relaxing factor (EDRF), an important 
vasodilator (113). Therefore, it is plausible that the reductions in aPWV seen in 
this study were due to neutralization of free radicals, and preserved EDRF 
activity. 
 
Vitamin C supplementation has been shown to restore NO activity by improving 
endothelium dependent vasodilation in adult patients with essential hypertension 
(135). The synergistic effects of vitamin C and E supplementation may exert a 
greater antioxidant effect beyond those effects in isolation.  In a randomized, 
double-blind, placebo-controlled study with a crossover design a combined 
vitamin C (1 gram) and vitamin E (400 IU) treatment was given for eight weeks to 
30 males (mean age = 50 yrs; range 42 to 60) with (never treated) essential 
hypertension (103).  While combined treatment of vitamin C and vitamin E did not 
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affect blood pressure, a significant reduction in aPWV was observed (pre to post, 
~9.1 to ~8.4 m/s, P < 0.01).   
 
The combined effect of antioxidant vitamins C together with E may provide 
optimal conditions for endothelial NO formation (54). Therefore, independent of 
changes in blood pressure, improvements in aortic stiffness were demonstrated 
in this male population of untreated hypertensives that is possibly due to 
decreases in vascular oxidative stress, and enhanced NO bioavailability.  Yet it 
remains to be determined whether apparently healthy middle aged adults would 




The first-line approach for prevention and treatment of most CVD risk factors is 
lifestyle & behavior modifications (137).  Regular aerobic exercise is a beneficial 
way to lose weight, and promotes arterial compliance.  The impact of excessive 
reduced aerobic fitness and excessive body mass on arterial stiffness is clear: 
The less fit and larger you are, the stiffer your arteries, independent of age (124). 
Thus, the physiological basis of weight gain (or weight loss) ultimately points 
back to the law of conservation of energy, which states that energy cannot be 
created or destroyed but rather changes forms.  
 
Because food provides the human body with energy, and is accumulated then 
subsequently stored in adipose tissue, obesity can best be explained as a 
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condition of excessive caloric intake relative to caloric expenditure. The health 
benefits of a lifestyle modification such as weight loss can therefore be achieved 




Among normotensive overweight/obese young adults, weight loss is associated 
with a reduction in aortic stiffness (25). After a 1-year lifestyle intervention 
(diet/physical activity/reduced sodium), aPWV significantly decreased by 0.581 
m/s after 6 months (P < 0.0001), by 0.32 m/s (P = 0.02) and after 12 months (25). 
This 1-year intervention resulted in an average weight loss of 6.4% (P < 0.05).  
Additionally, systolic blood pressure, triglycerides, CRP, insulin, and leptin 
decreased (P < 0.05); whereas, HDL cholesterol increased (P < 0.05).  
 
Additional studies have also demonstrated the effectiveness of lifestyle 
intervention on arterial stiffness in populations with greater CVD risk.  Obese 
men (mean age = 45 ± 2 yrs; BMI = 30 ± 1 kg/m2) were placed on a low-calorie 
lifestyle intervention (1,380 kcal/day) for 12 weeks. aPWV significantly decreased 
from 9.79 ± 0.45 to 9.18 ± 0.29 m/s (P < 0.05).  Additionally, plasma endothelin-1 
(a vasoconstrictor) significantly decreased from 1.9 ± 0.1 to 1.3 ± 0.3 pg/mL (P < 
0.01), and plasma nitrite/nitrate significantly increased from 24 ± 3 to 39 ± 4 
μmol/L (P < 0.01), suggesting that enhanced endothelial function is responsible 
for the reduction (9%, P < 0.01) in aortic stiffness following weight loss due to a 
low-calorie diet.  Other physiological variables that changed over the course of 
 39 
the 12-week weight loss intervention were total cholesterol, triglycerides, and 
blood glucose (P < 0.05) (88).  
 
Furthermore, a 12-week hypocaloric diet (1,200 to 1,500 kcal/day) administered 
to 25 overweight/obese, middle-aged and older adults (16 females; 9 males; 
mean age = 61.2 ± 0.8 yrs; BMI = 30.0 ± 0.6) demonstrated a significant 
reduction in aPWV by 1.87 ± 0.29 m/s (P < 0.05) (31). The magnitude of this 
improvement in arterial stiffness was positively related to the percent weight loss 
(r = 0.59; P < 0.05).  Additionally, brachial and aortic systolic blood pressures, 
triglycerides, total cholesterol, and glucose were significantly reduced (P < 0.05).  
Notably, the observed reductions in arterial stiffness in this study (~ 1.5 to 2.0 
m/s) would translate into a reversal of age-related arterial stiffening by ~15 to 20 
years (31). 
 
SUMMARY OF LITERATURE REVIEW 
 
Large elastic artery dysfunction is a major cause of premature mortality and 
incident cardiovascular events such as myocardial infarction, stroke, and heart 
failure.  The primary cause of cardiovascular disease as a result of aortic 
stiffness is increased wave reflections, afterload, and reduced coronary perfusion 
pressure.  These two factors combined elevates the left ventricular oxygen 
consumption values which is associated with enlargement of the myocardium.  
And, the increased wave reflection and afterload significantly affects left 
ventricular filling and emptying patterns.  In addition, prospective trials indicate, 
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after adjustment of traditional CVD risk factors, that increased aortic stiffness is 
injurious to target organs such as the brain, heart, and kidneys.  Indeed, the 
increased pulsatility that results with greater aortic stiffness is essentially 
tantamount to increased kinetic energy, which is destructive to the 
microcirculation, specifically the endothelium.  With the global rates of obesity  
increasing steadily, it is becoming increasingly important to understand lifestyle 
contributors to aortic stiffness, which would benefit public and community health.
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CHAPTER THREE:  METHODS 
 
OVERVIEW OF EXPERIMENTAL APPROACH 
 
This study employed a cross-sectional, observational design to examine the 
relationship between global, lifestyle contributors to CVD risk in apparently 
healthy middle-aged males.  In total, 54 men were recruited for participation from 
around the University of Kentucky community by means of advertisement.  Two 
men were excluded due to hypertension.  Thus, 52 men completed this study.  
Each subject was required to visit the Exercise Physiology Laboratory in Seaton 
Building two times, with each visit lasting approximately one hour.  Although 
complete details regarding each testing component will be provided later in this 
section, an overview of the study approach is as follows.  The initial day of testing 
examined body composition with bioelectrical impedance analysis, and assessed 
CVD risk with aortic stiffness and pulse wave analysis.  Then, a motion sensor 
(Fitbit Zip; tri-axial accelerometer) was programmed for each participant that was 
to be worn for the subsequent seven days.  Participants were instructed to not 
change their normal recreation habits during this tracking period.  During the 
second day of testing, each subject was tested for maximum grip strength and 
overall musculoskeletal fitness.  In addition, each subject completed an 
exhaustive web-based nutritional food frequency questionnaire designed to 




SUBJECT RECRUITMENT METHODS, PRIVACY, AND PAYMENT 
 
Subjects were actively recruited from Lexington and the surrounding 
communities, including from the University of Kentucky, through advertisement 
with the IRB-approved recruitment study flyer.  All data were stored in a locked 
filing cabinet located within a locked room.  Only study personnel had access to 
the private information of the study population.  The data does not contain any 
traceable information and was stored on a password-protected computer.  Data 
were used in a restricted manner and were summarized as group data.  Subjects 
did not receive cash reward for their participation.  Immediately after participation, 
each subject was offered an abbreviated report of his body composition, arterial 
stiffness, brachial blood pressure, and physical activity output.  All information 
was provided to the subject under the understanding that the data collected 
during the study period was for research purposes only.  Participants who were 
concerned with their cardiovascular health were advised to consult his primary 




Informed consent was voluntarily obtained from each subject before they were 
allowed to participate in the study.  The consent form was explained thoroughly 
and each subject had adequate time to read the form and ask questions.  The 
original signed consent form was secured and appropriately filed for review to 
ensure confidentiality of data collected.  If requested, all participants received a 




Subjects were enrolled into the study if they had a resting brachial blood 
pressure of less than 140 over 90 mmHg.  Additionally, each subject had to be a 
middle-aged man between the ages of 30 and 60 years of age.  We anticipated a 




Subjects were ineligible to participate in the study if resting brachial blood 
pressure was greater than 140 over 90 mmHg, indicating stage 1 hypertension 
according to the current guidelines of the American College of Sports Medicine 
(100).  Additionally, habitual smoking, orthopedic limitations, and adherence to 
CV medications such as anti-hypertensives, lipid lowering drugs, vasodilators, or 
others, and resting peripheral (brachial) blood pressure greater than or equal to 
140 over 90 mmHg indicating stage 1 hypertension. Women were not able to 
participate in this study in an effort to eliminate gender as a confounding variable.  
For example, middle aged men have significantly higher rates of CVD including 
angina, heart attack, stroke, and aneurysms compared with middle aged women 
(80).  While women appear to have an accelerated rate of CVD following 
menopause, this research project aims to study a relatively susceptible, 
vulnerable male population that is more likely to fall victim to premature mortality 
and CVD.  Thus, quantifying the relation of lifestyle factors and cardiovascular 
disease in middle-aged men, in isolation, would remove the known confounding 






Each subject was affixed with a tri-axial accelerometer, colloquially referred to as 
a fitness-tracking device (Fitbit Zip, Fitbit Inc., San Francisco, CA), which was 
worn on the right hip over the course of seven full days.  A compliance form was 
issued to each subject to ensure adherence to the study protocol.  Following this 
seven-day tracking period, physical activity data such as step counts, total 
distance, calories burned, and active minutes, were downloaded to a portable 
electronic tablet (iPad) for analysis.  Research has validated the motion sensor 




Each subject was required to complete a maximum handgrip strength test on a 
calibrated hydraulic hand dynamometer (Baseline, Fabrication Enterprises Inc., 
White Plains, NY) according to the manufacturer’s protocol.  Specifically, each 
subject squeezed the hand dynamometer and maintained 90 degrees of elbow 
flexion, an adducted shoulder, and a neutral wrist position while standing.  Three 
attempts were permitted with each hand in an alternating manner, and the peak 
value was recorded from each hand and data were summed.  To normalize 
absolute handgrip strength and allow for inter-subject comparison, the data were 
subsequently divided by the subject’s body weight and expressed as a ratio.   
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Following the maximum handgrip strength test, each subject was required to 
complete a sitting-rising test 5 times according to the standardized protocol (20). 
The test was performed with the subject barefoot, standing on a non-slippery 
yoga mat, and required the subject to lower himself from a standing position to a 
seated, erect posture on the floor.  After one trial was performed (serving as the 
familiarization trial), each subject was given verbal cues and coaching as to how 
to improve the SRT score.  The maximum score was ten possible points (5 points 
maximum for the sitting portion, and 5 points maximum for the rising portion).  A 
1-point deduction for using assistance such as a hand, knee, or side of the leg 
was taken from either sitting or rising portion.  Loss of control or balance resulted 
in a 0.5-point deduction.  In order to preserve validity and reliability, all five trials 
were video recorded with an electronic portable tablet (iPad) and were reviewed 
by a single investigator.  The video files were locked in a storage locker under a 
key, and only the study personnel had access to the device and data.  The 
highest sitting and rising score from any of the five trials was chosen as the 
component scores, which were summed to yield the composite SRT score, which 




Body composition was determined with conventional bioelectrical impedance 
analysis (BIA) by a single trained investigator with a single frequency (50 kHz) 
analyzer (BodyStat1500, BodyStat Ltd., Isle of Man, UK).  This tetrapolar, hand-
to-foot technique required the subject to be in the supine position.  The 
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electrodes were placed on the dorsal surface of right foot and ankle, and right 
wrist and hand. Subjects were evaluated after voiding the bladder, and were 
asked to refrain from strenuous exercise and consumption of caffeinated 
beverages the twelve hours preceding the measurements.   
 
Body composition variables measured included relative and absolute fat and fat 
free (lean) mass, total body water, impedance, resistance, and reactance at 50 
kHz.  Height was recorded with a wall-mounted stadiometer to the nearest 0.1 
cm and body mass was measured to the nearest 0.1 kg with a calibrated digital 
scale.   Anthropometric measures such as the circumference of the waist and hip 
were obtained according to current ACSM Guidelines for Exercise Testing and 
Prescription using a flexible measuring tape (100).  Each anatomical location for 
girth measurements was taken in duplicate to the nearest 0.1 cm, and the data 
were subsequently averaged.  Test, re-test reliability by the single investigator 




Each subject completed a 140 item, web-based National Institute of Health Diet 
History Questionnaire, addressing food frequency that was used for 
determination of overall dietary quality and adherence to the U.S. Dietary 
Guidelines regarding the previous one year.  The composite Healthy Eating 
Index (HEI) score ranges from 0 to 100, with higher scores representing higher 
dietary quality.  The HEI score is a composite of the 12 subcomponents, which 
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include: 1) Total vegetables, 2) Dark green vegetables and beans and peas, 3) 
Total fruit, 4) Whole fruit, 5) Refined grains, 6) Whole grains, 7) Total dairy, 8) 
Total protein foods, 9) Seafood and plant proteins, 10) Fatty acids, 11) Sodium, 
and 12) Empty calories (46).  Nutritional analyses were conducted on Diet*Calc 
1.5 (Diet*Calc Analysis Program, National Cancer Institute, Silver Spring, MD) 
and HEI component and composite scores were performed on SAS 9.4 (SAS 
Institute, Cary, NC). 
 
Large Elastic Artery (Aortic) Stiffness and Central Hemodynamics 
 
Aortic pulse wave velocity (aPWV) is considered the “gold standard” measure of 
arterial stiffness that uses non-invasive arterial tonometry, a commonly 
performed clinical technique (89).  Importantly, these noninvasive estimations of 
central (aortic) blood pressure and pulse wave velocity correlate well with 
invasive catheter-derived measurements acquired at the ascending aorta with a 
correlation coefficient of 0.91, demonstrated with the SphygmoCor device (32).  
Subsequently, the radial, carotid, and femoral artery locations were located and 
the pressure-sensing device, tonometer, was placed directly on the skin surface 
above the site of the strongest palpable pulse.  The non-invasive SphygmoCor 
pulse wave analysis (PWA) and pulse wave velocity (PWV) system (AtCor 
Medical, Sydney, Australia) were used to measure central blood pressure and 
hemodynamics and arterial stiffness, respectively, during resting conditions.  
Each subject was placed in the supine position and allowed to rest quietly for 10-
15 minutes prior to data acquisition.  PWA measures are reported as mmHg and 
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the speed of the pulse wave (PWV) from the carotid to femoral artery were 
calculated and presented in meters/second (145).  Test, re-test reliability by the 




Shapiro-Wilk tests were run on all variables to determine normality.  Levene tests 
were used to determine equal variances.  Pearson product-moment correlation 
analyses examined the association between lifestyle factors to CVD risk (S/DAY, 
SRT, GRIP/BW, FAT%, and HEI) and the primary health-related outcome 
measure, aPWV.  Partial correlation testing examined the age-adjusted 
associations between lifestyle factors and aPWV.  Multivariable linear regression 
analyses analyzed the predictive abilities of the lifestyle factors on aPWV.  
Backward stepwise regression analysis was run on all lifestyle factors to 
determine the strongest predictor of aPWV.   
 
Analysis of covariance (age as covariate) tested the association of lifestyle 
factors (expressed as categorical variables) with the continuous variable, aPWV, 
using the equal slopes test.  Two levels for quantiles were created based around 
(above and below) the median, whereas three levels for tertiles were divided 
from the ordered distribution of values, which were split into (nearly) equal parts 
(low, N = 17; moderate, N = 18; high, N = 17).  All pairwise multiple comparison 
procedures used the Holm-Sidak method.  The alpha level was set as P < 0.050.  
Pearson-product moment correlations are described as weak if r = 0.0 to 0.29, 
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moderate if r = 0.30 to 0.69, and strong if greater than or equal to 0.70.  All data 
were analyzed with SigmaPlot 12.3 (Systat Software Inc., San Jose, CA) and 
SPSS 23 (IBM SPSS Statistics, Armonk, NY). 
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CHAPTER FOUR:  RESULTS 
The descriptions of study variables used in this study are presented in Table 1A 
and statistical variables in Appendix A.  Descriptive statistics of the study 
population are presented in Table 1B.  Pearson product-moment correlation 
matrix representing the association of lifestyle factors with aortic stiffness and 
age is presented in Table 2A.  Specifically, S/DAY was not associated with 
aPWV (r = -0.02; P = 0.875), demonstrating no association between physical 
activity and aortic stiffness.  However, SRT and GRIP/BW were inversely 
associated with aPWV (r = -0.51; P = 0.000, r = -0.56; P = 0.000, respectively), 
demonstrating that greater physical function is associated with reduced CVD risk. 
FAT% was strongly associated with aPWV (r = 0.62; P = 0.000) and reflects the 
negative impact of obesity on large elastic artery stiffness.  HEI was associated 
with aPWV (r = -0.30; P = 0.033), demonstrating an important link between 
overall dietary quality and a novel risk factor for CVD risk.  Age was associated 
with aPWV (r = 0.56; P = 0.000), SRT (r = -0.30; P = 0.29), GRIP/BW (r = -0.45; 
P = 0.001), FAT% (r = 0.41; P = 0.003), but not HEI (r = 0.14; P = 0.337).  Due to 
the impact of aging on lifestyle factors and aortic stiffness, an age-adjusted 
partial correlation matrix was created, and is presented in Table 3.  Age and 
body fat-adjusted correlations are presented in Table 3.  Regarding the primary 
health outcome measure, aPWV, bivariate correlation adjusting for age is 
presented in Table 4.   
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Several age-adjusted multivariable linear regression models are presented in 
Table 5, which demonstrate the predictive power and relative contribution of each 
of the lifestyle factors on aPWV.  All models present the adjusted coefficient of 
determination (r2).  Model 1 used SRT and GRIP/BW as predictor variables and 
explained 44% of the variation in aortic stiffness; model 2 used FAT% and HEI as 
predictor variables and explained 50% of the variation in aortic stiffness; model 3 
used SRT and FAT% as predictor variables and explained 49% of the variation in 
aortic stiffness; model 4 used GRIP/BW and HEI as predictor variables and 
explained 47% of the variation in aortic stiffness; last, model 5 used SRT, 
GRIP/BW, FAT%, and HEI as predictor variables and explained 51% of the 
variation of aortic stiffness. 
 
The association of dietary quality and aPWV is presented in Table 6.  Specifically, 
after age-adjustment, two sub-components of the HEI-2010 that were associated 
with aPWV include refined grains (r = -0.36; P = 0.010) and fatty acids (r = -0.46; 
P = 0.001).  To clarify, reduced intake of refined grains resulted in a higher score 
on the refined grains sub-component.  Whereas, for fatty acids, greater 
consumption of unsaturated fatty acids relative to saturated fatty acids resulted in 
a higher score for this sub-component.  There was a trend for significance for 
total protein (r = -0.27; P = 0.057) and empty calories (r = -0.26; P = 0.065). 
 
Age-adjusted ANCOVA results for all categorical variables on aPWV are 
presented in conjunction with their associated figures.  For S/DAY, there was no 
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significant association to aPWV for any category (“quantiles, Table 7” “10,000 
steps, Table 8” and “groups, Table 9”; P = 0.678; P = 0.587; P = 0.253, 
respectively).  However, for the category “groups,” there was a significant age vs 
aPWV interaction (P = 0.010).  For SRT, the category “quantiles, Table 10” there 
was a significant difference between groups (P = 0.018), independent of age.  
Additionally, there was a significant difference for the category “groups, Table 11” 
(P = 0.020), independent of age.  Pairwise comparison analysis revealed a 
significant difference only between those who scored a 10 on SRT vs. < 9 (P = 
0.024).  For GRIP/BW, the category “quantiles, Table 12” there was a significant 
difference between groups (P = 0.042), independent of age.  Additionally, there 
was a significant difference for the category “tertiles, Table 13” (P = 0.012), 
independent of age.  A post hoc pairwise comparison analysis revealed a 
significant difference only between the lowest and highest tertile (P = 0.009).  
This technique compared the entities in pairs to judge specifically which groups 
were statistically different from one another.  For FAT%, the category “quantiles, 
Table 14” there was a significant difference between groups (P = 0.000), 
independent of age.  Last, for HEI, the category “quantiles, Table 15” there was a 
significant difference between groups (P = 0.003), independent of age. 
For all figures, the primary health outcome (dependent) measure is aPWV.  
Figure 1 represents the non-significant relationship of S/DAY, expressed as 
values above and below the median value of 7.372 steps per day.  Figure 2 
represents the non-significant relationship of S/DAY, expressed as above and 
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below 10,000 steps per day.  Figure 3 represents the non-significant relationship 
of steps per day, expressed in categories of 1) 4,999 steps or less per day, 2) 
5,000 to 9,999 steps per day, 3) 10,000 steps or more per day.  Figure 4 
represents the significant relationship of SRT, expressed as values above and 
below the median value of 9.5.  Figure 5 represents the significant relationship of 
muscular function, expressed in categories of 1) Less than 9 on SRT, 2) 9 on 
SRT, 3) 9.5 on SRT, and 4) 10 on SRT.  Figure 6 represents the significant 
relationship of GRIP/BW, expressed as values above and below the median 
value of 1.20 (or 120% of muscular strength relative to body weight).  Figure 7 
represents the significant relationship of relative muscular strength, expressed in 
categories of 1) 88 to 112% of body weight, 2) 113 to 127% of body weight, and 
3) 128 to 156% of body weight.  Figure 8 represents the significant relationship of 
FAT%, expressed as values above and below the median value of 18.2% body 
fatness.  Figure 9 represents the significant relationship of HEI, expressed as 
values above and below the median of 70.6 on the diet history questionnaire II.   
 
Age-adjusted correlation coefficients for all hemodynamic variables are 
presented in Appendix B.  Specifically, after adjusting for age, SRT was inversely 
associated with A-AIx75 (r = -0.30; P = 0.032).  GRIP/BW was inversely 
associated with A-AIx75 (r = -0.35; P = 0.012).  FAT% was associated with A-
SBP (r = 0.33; P = 0.17), A-DBP (r = 0.32; P = 0.23), A-AIx75 (r = 0.35; P = 
0.011), B-SBP (r = 0.29; P = 0.036), B-DBP (r = 0.28; P = 0.044), MP (r = 0.35; P 
= 0.011), and MAP (r = 0.32; P = 0.023).  HEI was inversely associated with RHR 
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(r = -0.36; P = 0.010).  Backward stepwise regression results are presented in 
Appendix C and indicate that AGE and FAT% are the strongest independent 


















































Mean arterial pressure (1/3rd B-PP + B-DBP)
Body weight (kg)
Height/stature (cm)
Body mass index (kg/m2)
Waist-to-hip circumference ratio (%)
Body fatness (%)
Fat-free mass (%)
Resting heart rate (bpm)
Brachial (peripheral) systolic blood pressure (mmHg)
Brachial (peripheral) diastolic blood pressure (mmHg)
Brachial (peripheral) pulse pressure (mmHg)
Arithmetic mean pressure (mmHg)
Total protein (0-5) [adequacy]
Seafood and plant protein (0-5) [adequacy]
Fatty acids (0-10) [adequacy]
Sitting-rising test score (0 to 10)
Pulse pressure amplification (%)
Subendocardial viability ratio (%) – also called Buckberg ratio
Aortic (central) systolic blood pressure (mmHg)
Aortic (central) diastolic blood pressure (mmHg)
Aortic (central) pulse pressure (mmHg)
Aortic (central) augmentation pressure (mmHg)
Sodium (0-10) [moderation]
Empty calories (0-20) [moderation]
Healthy eating index score (0 to 100) 
Total vegetables (0-5) [adequacy]
Dark greens and beans (0-5) [adequacy]
Total fruit (0-5) [adequacy]
Whole fruit (0-5) [adequacy]
Refined grains (0-10) [moderation]
Aortic (central) augmentation index (%)
Aortic (central) augmentation index (@ heart rate 75 bpm)
Aortic (central) pulse wave velocity (m/s)
Average step counts per day (7 day average)
Peak L+R handgrip strength/body weight (%)
Whole grains (0-10) [adequacy]
Total dairy (0-10) [adequacy]
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Table 1B.  Descriptive statistics of the study population (N = 52 men). 
Mean ± Std. Dev Std.Err Min Max Median
AGE 41.48 ± 8.49 1.18 30.00 59.00 40.00
WT 83.21 ± 12.98 1.80 59.60 123.90 80.70
HT 178.79 ± 7.14 0.99 164.20 195.50 178.40
BMI 25.91 ± 3.31 0.46 19.90 40.00 25.40
WHR 0.88 ± 0.06 0.01 0.79 1.00 0.87
FAT% 18.41 ± 4.75 0.66 7.90 31.50 18.20
LEAN% 81.56 ± 4.75 0.66 68.50 92.10 81.60
RHR 63.25 ± 10.45 1.45 42.00 91.00 62.00
B-SBP 119.23 ± 9.59 1.33 100.00 138.00 119.50
B-DBP 72.67 ± 6.99 0.97 58.00 86.00 72.00
B-PP 46.56 ± 8.41 1.17 30.00 73.00 45.00
MP 87.67 ± 7.51 1.04 69.00 106.00 88.00
MAP 88.18 ± 6.89 0.96 71.99 103.32 88.48
PP-AMP% 148.48 ± 15.90 2.21 111.00 178.00 147.50
SEVR 171.81 ± 36.38 5.04 107.00 281.00 161.50
A-SBP 105.06 ± 8.54 1.18 85.00 126.00 105.00
A-DBP 73.56 ± 7.01 0.97 58.00 88.00 73.00
A-PP 31.60 ± 4.94 0.68 24.00 44.00 31.00
A-AP 3.57 ± 3.63 0.50 -5.00 11.00 3.25
A-AIx 10.96 ± 10.62 1.47 -14.00 32.00 10.50
A-AIx75 5.35 ± 11.58 1.61 -18.00 32.50 3.75
A-PWV 6.82 ± 0.87 0.12 5.60 9.40 6.60
S/DAY 8158.70 ± 3758.03 521.14 2339.14 18086.86 7372.64
GRIP/BW 1.21 ± 0.17 0.02 0.88 1.57 1.20
SRT 9.34 ± 0.84 0.12 6.00 10.00 9.50
HEI 70.87 ± 11.38 1.58 30.88 90.61 70.54
T-VEG 4.20 ± 1.15 0.16 1.00 5.00 5.00
DRK-GRNS-BNS 4.17 ± 1.49 0.21 0.00 5.00 5.00
T-FRUIT 3.81 ± 1.34 0.19 0.17 5.00 4.24
W-FRUIT 4.49 ± 0.99 0.14 0.09 5.00 5.00
R-GRAINS 8.32 ± 2.46 0.34 0.47 10.00 9.77
W-GRAINS 2.82 ± 1.96 0.27 0.04 8.06 2.34
T-DAIRY 6.36 ± 2.57 0.36 0.71 10.00 6.18
T-PRO 4.77 ± 0.72 0.10 1.16 5.00 5.00
SEA-PLNT-PRO 4.33 ± 1.21 0.17 0.60 5.00 5.00
F-ACIDS 6.00 ± 2.96 0.41 0.00 10.00 6.20
SODIUM 4.66 ± 2.99 0.42 0.00 10.00 4.30
EMPTY 16.93 ± 4.64 0.64 0.00 20.00 19.19
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Table 2A.  Correlation matrix representing the association of lifestyle factors with 
aortic stiffness and age. 
A-PWV S/DAY SRT GRIP/BW FAT% HEI 
AGE 
0.56 0.05 -0.30 -0.45 0.41 0.14 r 
0.000 0.722 0.029 0.001 0.003 0.337 P 
A-PWV 
-0.02 -0.51 -0.56 0.62 -0.30 r 
0.875 0.000 0.000 0.000 0.033 P 
S/DAY 
0.02 0.03 0.01 -0.10 r 
0.881 0.831 0.969 0.496 P 
SRT 
0.58 -0.62 0.17 r 
0.000 0.000 0.228 P 
GRIP/BW 
-0.74 0.28 r 





Table 2B.  Age-adjusted correlation matrix representing the association of 
lifestyle factors with aortic stiffness. 
S/DAY SRT GRIP/BW FAT% HEI 
A-PWV 
-0.06 -0.44 -0.41 0.51 -0.45 r 
0.669 0.001 0.003 0.000 0.001 P 
S/DAY 
0.04 0.06 -0.02 -0.11 r 
0.789 0.676 0.908 0.465 P 
SRT 
0.52 -0.57 0.22 r 
0.000 0.000 0.114 P 
GRIP/BW 
-0.68 0.39 r 




Table 3.  Age and body fat-adjusted correlation matrix representing the 
association of lifestyle factors with aortic stiffness. 
-0.06 -0.20 -0.10 -0.26 r
0.671 0.160 0.505 0.065 P 
0.04 0.07 -0.13 r
0.807 0.647 0.365 P 
0.22 -0.09 r







S/DAY SRT GRIP/BW HEI
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Table 4.  Age-adjusted relationship of lifestyle factors with aortic stiffness. 
Factor Outcome
r r² P r r² P
S/DAY aPWV -0.02 0.00 0.875 -0.06 0.00 0.669
SRT aPWV -0.51 0.26 0.000 -0.44 0.19 0.001
GRIP/BW aPWV -0.56 0.31 0.000 -0.41 0.17 0.003
FAT% aPWV 0.62 0.38 0.000 0.51 0.26 0.000
HEI aPWV -0.30 0.09 0.033 -0.45 0.21 0.001
Age-adjustedBivariate correlation
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Table 5.  Age-adjusted multivariable linear regression models predicting aortic 
stiffness with lifestyle factors. 
Model P (ANOVA) Adj r² Predictors Outcome B SE B P SEE
Constant 9.258 1.345 0.000
SRT -0.274 0.133 0.044
GRIP/BW -1.212 0.709 0.094
Constant 4.931 0.809 0.000
FAT% 0.063 0.023 0.008
HEI -0.017 0.008 0.065
Constant 5.863 1.602 0.000
SRT -0.190 0.133 0.160
FAT% 0.065 0.025 0.010
Constant 7.926 1.048 0.000
GRIP/BW -1.317 0.644 0.046
HEI -0.022 0.009 0.013
Constant 7.684 2.031 0.000
SRT -0.208 0.134 0.128
GRIP/BW -0.155 0.799 0.847
FAT% 0.037 0.031 0.242
































HEI -0.30 0.09 0.033 -0.45 0.21 0.001
T-VEG -0.12 0.01 0.398 -0.13 0.02 0.377
DRK-GRNS-BNS -0.08 0.01 0.556 -0.09 0.01 0.510
T-FRUIT 0.07 0.00 0.625 -0.11 0.01 0.460
W-FRUIT -0.03 0.00 0.824 -0.15 0.02 0.305
R-GRAINS -0.25 0.06 0.072 -0.36 0.13 0.010
W-GRAINS 0.16 0.03 0.253 -0.08 0.01 0.589
T-DAIRY -0.11 0.01 0.446 0.01 0.00 0.923
T-PRO -0.14 0.02 0.319 -0.27 0.07 0.057
SEA-PLNT-PRO -0.10 0.01 0.497 -0.17 0.03 0.236
F-ACIDS -0.31 0.10 0.026 -0.46 0.21 0.001
SODIUM -0.18 0.03 0.201 -0.21 0.04 0.137
EMPTY -0.20 0.04 0.160 -0.26 0.07 0.065
r r² P r r² P
Age-adjustedOutcome:  aPWV
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Table 7.  ANCOVA results showing age-adjusted aPWV means for S/DAY on 
quantiles. 
 
Factor Category Level Adj means SE P P (age x aPWV)
1) Above median 6.779 0.144
2) Below median 6.864 0.144
Quantiles 0.678 0.417S/DAY
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Factor Category Level Adj means SE P P (age x aPWV)
1) Above 6.860 0.198
2) Below 6.807 0.119
10,000 steps 0.818 0.547S/DAY
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Factor Category Level Adj means SE P P (age x aPWV)
1) ≤ 4,999 7.113 0.218
2) 5,000 to 9,999 6.683 0.139
3) ≥ 10,000 6.858 0.194
Groups 0.253 0.010S/DAY
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Factor Category Level Adj means SE P P (age x aPWV)
1) Above median 6.571 0.140
2) Below median 7.053 0.135
Quantiles 0.018 0.167SRT
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Factor Category Level Adj means SE P P (age x aPWV)
1) < 9 on SRT 7.341 0.212
2) 9 on SRT 7.021 0.214
3) 9.5 on SRT 6.608 0.276
4) 10 on SRT 6.563 0.137
Groups 0.020 0.321SRT
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Table 12.  ANCOVA results showing age-adjusted aPWV means for GRIP/BW 
on quantiles. 
 
Factor Category Level Adj means SE P P (age x aPWV)
1) Above median 6.589 0.148
2) Below median 7.053 0.148
Quantiles 0.042 0.155GRIP/BW
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Factor Category Level Adj means SE P P (age x aPWV)
1) Low 7.221 0.172
2) Moderate 6.823 0.160
3) High 6.419 0.175
Tertiles 0.012 0.438GRIP/BW
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Factor Category Level Adj means SE P P (age x aPWV)
1) Above median 7.214 0.126
2) Below median 6.429 0.126
FAT% Quantiles 0.000 0.579
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Factor Category Level Adj means SE P P (age x aPWV)
1) Above median 6.527 0.131
2) Below median 7.115 0.131
HEI Quantiles 0.003 0.169
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CHAPTER FIVE:  DISCUSSION 
 
The utility of aortic stiffness as a biomarker has been clearly established in large 
population-based, follow-up studies that control for traditional CVD risk factors 
(11).  The focus of the present study was to control for the normal and gradual 
aortic stiffening process caused with advancing age, and to examine global 
contributors of early vascular aging that may provide insight into key health-
related behaviors associated with its presence.  Due to the confounding influence 
of gender on aortic stiffness, women were excluded from participation in this 
investigation (40, 80). 
 
In the present study, greater muscular strength and function were associated 
with reduced aortic stiffness, after statistically adjusting for age.  In addition, after 
age adjustment greater dietary quality was associated with reduced aortic 
stiffness.  Perhaps most interesting was that physical activity was not associated 
with any measure of CVD risk including aortic stiffness in the present study.  
Thus, in an apparently healthy, physically active population, a large percentage 
of the variation in aPWV was able to be explained with a novel measure of 
physical function and by assessing adherence to the United States Dietary 
Guidelines.  There is research that suggests in a physically inactive population 
achieving greater step counts per day positively influences measures of CV 
health, such as biomarkers of the metabolic syndrome including total and HDL 
cholesterol, insulin resistance, and body fatness (23).  
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The total number of step counts per day (averaged over 7 days) was directly 
assessed with a tri-axial accelerometer mounted on the right hip.  We showed 
that physically active, apparently healthy middle aged men who stepped more 
per day were not those who had reduced aortic stiffness.  In fact, the total 
number of step counts per day was not associated with aortic stiffness, and was 
unable to explain any of the variation of aPWV in this study.  While the 
recommendation of acquiring greater than or equal to 10,000 steps per day has 
been associated with positive cardiometabolic health improvements, it may be a 
worthwhile target for a physically inactive population (23). 
 
Step-based activity is undoubtedly important for breaking up periods of physical 
inactivity, which has been associated with elevated CVD risk (52).  Yet, the 
differences in aPWV between men who stepped less than 5,000 steps per day 
compared with those who stepped more than 10,000 steps per day were not 
significant.  To reiterate, the men in this study were physically active, hence 
increasing the number of step counts per day was not correlated with reduced 
aortic stiffness.  Tracking the total number of step counts per day is an indicator 
of physical activity, and a metric that has been associated with aortic stiffness.  
The Busselton Health Study, a large prospective, follow-up investigation, showed 
that increased physical activity (measured with a questionnaire) was associated 
with reduced CVD risk and all-cause mortality in middle aged and older adults 
(47).  Moreover, several studies have demonstrated that more total physical 
activity is associated with reduced aortic stiffness, both in young and elderly 
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populations (57, 66, 115).  For example, in young children who wore a 
pedometer for 7 days, more step counts per day was inversely associated with 
aPWV (115).  In older adults, inverse associations between pedometer step 
counts (worn for 3 days) were also demonstrated with aPWV (57).  And, a 
research-grade accelerometer worn for 7 days showed greater caloric 
expenditure per day was inversely associated with aPWV (66).  For middle aged 
men and women greater step counts per day was associated with the attenuation 
of aortic stiffness (3, 44, 61, 74, 93).  To clarify, in each of these 5 studies that 
used both men and women, physical activity levels were determined with an 
accelerometer that was worn for 7 consecutive days, which was associated with 
reduced aortic stiffness. 
 
However, the population in this study was an apparently healthy, middle aged 
male cohort.  Because men and women present different CVD etiologies and 
disease courses, controlling for gender as a confounding variable is essential to 
examine the relationship of physical activity and aortic stiffness in a single 
isolated population (80).  To date, there has only been one study that has 
examined the relationship of physical activity (measured with a questionnaire) 
and aPWV in middle aged men (99).  In their study, physical activity expressed 
as greater than or equal to 4 METs (hours per week) was not statistically 
associated with aPWV.  These data parallel our findings, indicating that among 
middle aged men neither intensity nor step counts was able to predict aPWV in 
otherwise healthy adults. Furthermore, the central limitation in the study that 
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indicated no relationship between exercise intensity and aortic stiffness, was that 
physical activity was not measured directly but rather was estimated from a 
questionnaire.  Tracking physical activity with an accelerometer provides 
dissimilar results when compared with estimations drawn from pencil-and-paper 
responses (70).  Therefore to determine free-range step counts, exercise 
intensity, and energy expenditure, it is paramount that each individuals’ actual 
day-to-day movements and levels of physical activity are accounted for directly, 
not estimated. 
 
Another significant finding in the present study was that physical function is a key 
determinant of aortic stiffness.  Physical function is typically measured by the 
VO2MAX (cardiorespiratory fitness) and muscular strength/endurance, and in 
general is associated with greater longevity and reduced CVD risk (53).  
Furthermore, when physical function is optimized, the perceived level of difficulty 
of functional tasks and activities of daily living are reduced (30).  Regarding CVD 
risk, however, there is a shortage of research that has related novel measures of 
physical function that incorporate both aerobic and anaerobic components of 
fitness with aortic stiffness.  For instance, one study showed reduced aortic 
stiffness was associated with greater maximal walking speed and more total 
distance covered in a functional walking test in apparently healthy older adults 
(45).  Increased walking speed and covering more total distance may be not 
tantamount to VO2MAX per se, but the functional system involved with gait 
performance is reflected in maximal oxygen consumption (21).  For older adults, 
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assessments that are geared at improving activities of daily living will directly 
benefit the quality of life (97).   
 
Interestingly, increased grip strength has been associated with greater maximal 
walking speed and leg strength (36).  The use of handgrip strength has also been 
used as a predictor of future disability, CVD risk, and all-cause mortality appears 
to be a viable metric of physical function that has clinical utility and prognostic 
value (67, 105).  Increased grip strength is associated with greater lean muscle 
mass in older years, which is associated with reduced aortic stiffness (116).  The 
use of handgrip strength in the present study was chosen as a measure of upper 
body muscular strength that is well established and clinically relevant.  
 
Furthermore, peak handgrip strength values from both hands averaged by body 
weight allowed inter-subject comparison, and therefore reflected relative 
muscular strength.  In this study, individuals in the highest tertile, or those at or 
above 128% of handgrip power relative to body weight, had significantly reduced 
aortic stiffness compared with those in the lowest or middle tertile.  The relation 
of greater muscular strength and reduced aortic stiffness was independent of age.   
 
While greater muscular strength in early adulthood has been correlated with 
increased aortic stiffness (13, 87, 96), there exists one well-designed study that 
has shown greater relative muscular strength (measured with 1RM bench 
press/body weight) is associated with reduced aortic stiffness (34).  In older 
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adulthood, for example, greater muscular strength appears to be definitively 
cardio-protective, and is particularly associated with reduced aortic stiffness 
(116).  Because the current study population was middle aged, thus it appears 
that greater muscular strength is a favorable physical adaptation that is 
associated with reduced aortic stiffness.  This is the first time that the association 
of greater handgrip strength in middle aged men has been associated with 
reduced aortic stiffness, indicating improved vascular health among those with 
higher levels of relative muscular strength.  Perhaps the underlying mechanism 
explaining the strength-related differences and increased aortic stiffness is the 
inflammatory status.  For example, in older men, higher serum C-reactive protein 
levels, an important biomarker associated with greater CVD risk, were 
independently related to lower handgrip strength and reduced walking speed (78). 
Because skeletal muscle operates as a secretory organ, the cytokine and peptide 
profile is strongly dependent upon physical activity, specifically, muscular 
contractions (98).  In that way, it is plausible that individuals with greater physical 
function and strength, and reduced aortic stiffness, were those who had an 
optimized myokine response that favorably interacted with the vasculature (147).  
Taken together, perhaps the reduction in aortic stiffness in apparently healthy 
middle aged men was due to reduced serum and myokine pro-inflammatory 
expression. 
 
In the present study, greater handgrip strength was associated with a novel test 
of physical function, the SRT  Because the sitting-rising test score was 
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associated with relative muscular strength, we demonstrated internal validity 
between the two chosen independent measures of physical function.  The SRT is 
unique in that it assesses overall musculoskeletal function such as strength, 
balance, coordination, and flexibility (19, 20).  In that way, the SRT is a safe and 
simple assessment tool that integrates the traditional measures of physical 
function such as cardiorespiratory fitness with muscular strength and endurance.  
In addition, the sitting-rising test score is a strong predictor of all-cause mortality 
that adds relevant information regarding functional capabilities and outcomes in 
adults with low CVD risk (20).  In this study, a greater SRT score was associated 
with reduced aortic stiffness, independent of age, indicating a functional 
relationship between the cardiovascular and muscular nexus. 
 
In conjunction with greater physical activity and function, focusing on nutrition, 
specifically dietary quality, is another first-line therapy used to minimize CVD risk.  
While the obesity trend is continually climbing, the overall dietary quality of 
American adults has been improving over the last 20 years (150).  Data from the 
Framingham Heart Study has indicated that younger adults, in particular, benefit 
from greater adherence to the United States Dietary Guidelines in terms of 
reduced peripheral blood flow velocity and reduced arterial wave reflection (119).   
This study indicated that overall dietary quality, measured with the validated and 
reliable HEI score (46), was associated with reduced aortic stiffness independent 
of age.  These data coincide with meta-analyses and systematic reviews that 
have shown a higher Healthy Eating Index score was associated with reduced 
 78 
all-cause, and CVD related mortality (121).  In fact, middle aged adults can 
expect approximately a 1/3rd reduction in CVD risk with greater adherence to the 
United States Dietary Guidelines (110).  Furthermore, two sub-components of the 
dietary analysis that largely contributed to the relationship of Healthy Eating 
Index and reduced aortic stiffness were refined grains and fatty acids.  Previous 
research has indicated that greater fruit and vegetable consumption is associated 
with reduced aortic stiffness in early adulthood (1).  This study is the first to 
indicate that a reduction in refined grain consumption is associated with reduced 
aortic stiffness.  And, the fatty acid profile – specifically, greater than or equal to 
2.5 grams of unsaturated to 1 gram of saturated fatty acid ratio – was associated 
with reduced aortic stiffness.  Prior investigations have shown that greater 
consumption of unsaturated fatty acids, particular the omega-3 variety, is 
associated with reduced CVD risk (49, 75).  Well designed, long-term clinical 
trials have shown the favorable effects of omega-3 fatty acids on aortic stiffness 
is through a reduction in vascular inflammation (128, 140).  For instance, the first 
study showed that 12 weeks of omega-3 fatty acids supplementation at 2 grams 
per day in young adults reduced circulating levels of TNF alpha, IL-6, and was 
able to reduce aortic stiffness (128).  Whereas, in the second study, 12 weeks of 
omega-3 fatty acid supplementation at 2 grams per day in middle aged adults, 
was successful in reducing circulating levels of IL-6 in conjunction with aortic 
stiffness (140).  This study is the first to demonstrate an observational link 
between the composition of fatty acids within the diet over the last 1 year and 
aortic stiffness.  The explanation accounting for the association of reduced 
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refined grain consumption and reduced aortic stiffness may be due to a reduction 
in risk of type 2 diabetes – a proposed contributor of AGEs formation within the 
artery leading to greater aortic stiffness (7, 148). 
 
Traditionally, first-line therapies that are used to minimize CVD risk are exercise-
based.  For example, modifying undesirable health-related behaviors such as 
reducing physical inactivity and improving physical dysfunction favorably 
improves CVD risk stratification.  Although obesity trends in the United States 
have leveled off (129), it is worthwhile to assess the utility of traditional first-line 
approaches as prophylactic therapy against CVD risk.  For instance, promoting 
greater physical activity and adherence to habitual exercise is the foundation of 
ACSM’s “exercise is medicine” agenda  (139).  Exercise scientists and 
physiologists understand the potential benefits of adherence to regular physical 
activity and structured exercise as it relates to improved CVD risk stratification.  
However, the fundamental evaluation of any approach that involves modifying 
public health should be results-based.  For example, although it is evident that 
exercise is medicine, according to the agenda of the ACSM, most aging 
Americans are simply not motivated to actually do exercise (58).  In that regard, 
simply promoting more (and more) physical activity does not appear to be 
effective in directly addressing the obesity epidemic, physical fitness, or CVD risk 
stratification for millions of Americans.  In brief, the promotion of exercise is only 
worthwhile if the American public actually recognizes and changes their 
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undesirable health-related lifestyle behaviors, leading to an objective reduction in 
CVD risk. 
 
Results from the stepwise regression analysis indicated that after age, body 
fatness was the strongest predictor of aPWV in this study cohort.  Given that the 
primary risk factor for CVD risk is age, the results of this study confirm that 
obesity is a powerful indicator of aortic stiffness (142).  Interestingly, elevated 
body fatness in early adulthood has been associated with reduced aortic 
stiffness; however, this paradoxical association continues until approximately 50 
years of life, after which time the relationship becomes proportional, not inverse 
(26).  It appears as though the location of excessive fat mass (ie the fat depot) 
has a differing influence of aortic stiffness.  For instance, results from the 
Amsterdam Growth and Health Longitudinal Study demonstrated among healthy 
adults that increases in trunk mass and decreases in peripheral fat mass were 
associated with accelerated arterial stiffening (120).  Although in its infancy, one 
proposed mechanism explaining vascular disease in the context of the fat depot 
is enhanced autocrine communication between the perivascular adipose regions 
and local vasculature, which appears to increase the vasoconstrictive phenotype 




Novel lifestyle contributors to aortic stiffness include physical function and overall 
dietary quality.  For example, the sitting-rising test score which determines 
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overall musculoskeletal fitness by integrating aspects of muscular strength, 
balance, coordination, and flexibility may be used as a cardiovascular health 
screen in apparently healthy, middle aged men.  And, greater adherence to the 
United States Dietary Guidelines, assessed with the validated and reliable 
Healthy Eating Index score is associated with reduced aortic stiffness, in part due 
to reduced refined grain consumption and greater unsaturated fatty acid intake.  
For apparently healthy, active middle aged men, focusing on improving physical 





The Fitbit Zip as an objective measure of step counts has been previously 
validated (141).  However, this model of the Fitbit does not track metabolic data 
such as energy expenditure or heart rate.  Due to the influence of resistance-
based exercise on these variables, but not step counts, it is possible that the men 
in this study who had stepped very minimally were those who had participated in 
stationary exercise such as weightlifting.  In fact, anecdotally, several of the 
participants directly informed study personnel that this was the case.  Additionally, 
cardiovascular exercise such as cycling or yoga would not register as moderate-
intensity physical activity or greater step counts on the accelerometer used in this 
study.  Therefore, the attribution of step counts as a metric representing actual 
physical activity levels is not justified in all participants.  It would have been 
worthwhile to incorporate metabolic data such as energy expenditure or heart 
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rate into physical activity determination.  Given the scope of this project, the need 




Exploring the differences in gender for the same outcome measures would help 
to clarify the isolated associations of aortic stiffness and key health-related 
behaviors associated with CVD risk.  Because younger populations are able to 
maintain relatively low CVD risk in spite of unfavorable lifestyle habits, it would be 
worthwhile to explore novel measures of physical function in an effort to explain 
the variation of aortic stiffness independent of body composition.  Molecular 
study should focus on the relationship between inflammation and vascular health.     
Last, it is important to consider the relationship of fat free (lean) muscle mass on 
aortic stiffness.  Unpublished data from our lab indicate that in young adult men 
with greater levels of fat free mass are those who have increased aortic stiffening.  
One possible cause may be a skeletal muscle phenotypic difference due to 
excessive hypertrophy.  The relationship between muscle hypertrophy and aortic 
stiffness would be an interesting area for further exploration, and possibly one 





























Relative change in r² with each step of multiple linear regression
Adjusted coefficient of determination for # of variables in the equation
Probability of obtaining an effect, alpha (α) level ≤ 0.050
Lifestyle factor of CVD disease, predictor or independent variable
Analysis of covariance
Response or dependent variable
Unstandardized regression coefficient
Standard error of the unstandardized regression coefficient
Standard error of the estimate
The y-intercept is the expected mean value of Y when all X=0
Age-adjusted mean values of aPWV
Probability of obtaining an interaction effect
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r r² P r r² P
S/DAY PP-AMP% 0.09 0.01 0.509 0.19 0.04 0.193
SRT PP-AMP% 0.30 0.09 0.032 0.12 0.01 0.387
GRIP/BWPP-AMP% 0.39 0.15 0.004 0.11 0.01 0.457
FAT% PP-AMP% -0.32 0.10 0.020 -0.05 0.00 0.732
HEI PP-AMP% -0.28 0.08 0.048 -0.26 0.07 0.069
Factor Outcome
r r² P r r² P
S/DAY SEVR 0.27 0.07 0.052 0.27 0.07 0.057
SRT SEVR 0.23 0.05 0.105 0.27 0.07 0.059
GRIP/BW SEVR 0.17 0.03 0.225 0.24 0.06 0.096
FAT% SEVR -0.15 0.02 0.283 -0.20 0.04 0.150








r r² P r r² P
S/DAY A-SBP -0.13 0.02 0.360 -0.14 0.02 0.319
SRT A-SBP -0.27 0.07 0.051 -0.23 0.05 0.107
GRIP/BW A-SBP -0.27 0.07 0.052 -0.21 0.04 0.141
FAT% A-SBP 0.38 0.14 0.006 0.33 0.11 0.017
HEI A-SBP -0.12 0.02 0.385 -0.15 0.02 0.280
Factor Outcome
r r² P r r² P
S/DAY A-DBP -0.12 0.01 0.401 0.14 0.02 0.326
SRT A-DBP -0.19 0.04 0.175 -0.11 0.01 0.438
GRIP/BW A-DBP -0.33 0.11 0.018 -0.23 0.05 0.110
FAT% A-DBP 0.40 0.16 0.004 0.32 0.10 0.023
HEI A-DBP -0.15 0.02 0.278 -0.21 0.04 0.150
Factor Outcome
r r² P r r² P
S/DAY A-PP -0.06 0.00 0.648 -0.06 0.00 0.667
SRT A-PP -0.22 0.05 0.121 -0.25 0.06 0.077
GRIP/BW A-PP -0.02 0.00 0.913 -0.05 0.00 0.722
FAT% A-PP 0.09 0.01 0.518 0.13 0.02 0.363










r r² P r r² P
S/DAY A-AP -0.02 0.00 0.900 -0.07 0.00 0.633
SRT A-AP -0.36 0.13 0.010 -0.22 0.05 0.126
GRIP/BW A-AP -0.44 0.19 0.001 -0.21 0.04 0.141
FAT% A-AP 0.45 0.20 0.001 0.27 0.07 0.059
HEI A-AP 0.13 0.02 0.362 0.05 0.00 0.715
Factor Outcome
r r² P r r² P
S/DAY A-AIx 0.01 0.00 0.950 -0.04 0.00 0.791
SRT A-AIx -0.36 0.13 0.009 -0.22 0.05 0.125
GRIP/BW A-AIx -0.47 0.22 0.000 -0.23 0.05 0.100
FAT% A-AIx 0.45 0.20 0.001 0.25 0.06 0.076
HEI A-AIx 0.13 0.02 0.349 0.05 0.00 0.718
Factor Outcome
r r² P r r² P
S/DAY A-AIx75 -0.09 0.01 0.530 -0.15 0.02 0.281
SRT A-AIx75 -0.41 0.17 0.002 -0.30 0.09 0.032
GRIP/BW A-AIx75 -0.53 0.28 0.000 -0.35 0.12 0.012
FAT% A-AIx75 0.51 0.26 0.000 0.35 0.12 0.011









r r² P r r² P
S/DAY RHR -0.25 0.06 0.079 -0.24 0.06 0.086
SRT RHR -0.19 0.03 0.188 -0.22 0.05 0.117
GRIP/BW RHR -0.20 0.04 0.161 -0.27 0.07 0.060
FAT% RHR 0.20 0.04 0.161 0.26 0.07 0.071
HEI RHR -0.37 0.13 0.008 -0.36 0.13 0.010
Factor Outcome
r r² P r r² P
S/DAY B-SBP -0.07 0.00 0.624 -0.06 0.00 0.670
SRT B-SBP -0.14 0.02 0.339 -0.21 0.04 0.144
GRIP/BW B-SBP -0.05 0.00 0.730 -0.16 0.02 0.272
FAT% B-SBP 0.19 0.03 0.190 0.29 0.09 0.036
HEI B-SBP -0.25 0.06 0.077 -0.23 0.05 0.109
Factor Outcome
r r² P r r² P
S/DAY B-DBP -0.13 0.02 0.366 -0.15 0.02 0.286
SRT B-DBP -0.16 0.03 0.257 -0.07 0.01 0.623
GRIP/BW B-DBP -0.32 0.10 0.021 -0.21 0.04 0.146
FAT% B-DBP 0.38 0.14 0.006 0.28 0.08 0.044









r r² P r r² P
S/DAY B-PP 0.03 0.00 0.850 0.06 0.00 0.682
SRT B-PP -0.02 0.00 0.879 -0.20 0.04 0.155
GRIP/BW B-PP 0.21 0.04 0.138 -0.02 0.00 0.919
FAT% B-PP -0.10 0.01 0.477 0.12 0.01 0.395
HEI B-PP -0.18 0.03 0.193 -0.14 0.02 0.342
Factor Outcome
r r² P r r² P
S/DAY MP -0.16 0.02 0.268 -0.17 0.03 0.232
SRT MP -0.22 0.05 0.125 -0.17 0.03 0.246
GRIP/BW MP -0.29 0.08 0.039 -0.23 0.05 0.113
FAT% MP 0.40 0.16 0.004 0.35 0.12 0.011
HEI MP -0.21 0.04 0.135 -0.25 0.06 0.083
Factor Outcome
r r² P r r² P
S/DAY MAP -0.12 0.01 0.401 -0.13 0.02 0.377
SRT MAP -0.17 0.03 0.226 -0.14 0.02 0.325
GRIP/BW MAP -0.24 0.06 0.089 -0.21 0.04 0.148
FAT% MAP 0.34 0.11 0.014 0.32 0.10 0.023





APPENDIX C:  STEPWISE REGRESSION RESULTS 
 
Step # Vars. Entered Vars. Removed r² Delta r² P
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